Diagnostic Radiology: Gastrointestinal and Hepatobiliary Imaging Niranjan Khandelwal, Arun Kumar Gupta, Deep Narayan Srivastava, Anju Garg, Raju Sharma
INDEX
Page numbers followed by f refer to figure and t refer to table.
A
Abdomen 8, 533f, 543f
nontraumatic acute 468
postoperative 574, 575
protocol 13t
tuberculosis of 151
Abdominal distension 341f, 526f, 577, 580, 586
Abdominal pain, chronic postprandial 513f
Abdominal wall 599f
collaterals, superficial 341
injury 502
Abdomino-perineal excision of rectum 138
Abrupt termination of mesenteric vessels 501
Abscess 159, 515f, 556f
appendicular 515f
coalescing, small 267f
postoperative 576
abdominal 476
Absorption rate, specific 12
Acalculous cholecystitis 363
Acetic acid
ablation 243, 307
injection 308
Achalasia 32, 34f
Achlorhydria 465
Acid-induced injury 38
Acoustic radiation force impulse 6, 227, 237, 280, 415
Acquired immune deficiency syndrome 36, 213, 215, 362
Actinomycosis 226
Adenocarcinoma 9, 43, 51t, 64, 78, 89
jejunum 90, 91
small bowel 91t
Adenoma 77, 84
Adenomatoid tumor 529
Adenomatous
hyperplastic nodule 262
polyps 57, 58, 77
Adenosine deaminase 151
AIDS-related cholangiopathy 362
Air in biliary tree 472
Air-fluid level 482
Alcoholic liver disease 324
Alcohol 308
induced chronic pancreatitis 423f
Alcoholic
cirrhosis 221
hepatitis 221
Alkali ingestion 38
Alkaline phosphatase 224, 362
Alpha fetoprotein 240, 282
American Association for Study of Liver Diseases 240, 281
American Association for Surgery of Trauma 503
American College of Radiology 135, 174, 359
American College of Radiology Imaging Network 121
American Joint Committee on Cancer 48, 120
Amine precursor uptake 92
Aminotransferase 240
Amoebic abscess 267
Amylase 398
Amyloid
A protein 223
light chain protein 223
Amyloidosis 215, 223, 570
Anaplastic lymphoma kinase 75
Anechoic cyst 554
Anemia 234
Angiodysplasia 193
Angiogram 568f
Angiographic technique, steps of 311f
Angiography 17, 185, 546
Angiomyolipoma 248
Angiosarcoma 296, 298f, 563
Anorectal tuberculosis 147
Anorexia 234
Antegrade flow, continuous 6f
Antilactoferrin antibody 427
Antinuclear antibody 427
Anti-smooth muscle antibody 427
Antropyloric region 58
Aorta
abdominal 9f
caliber of abdominal 172f
Aortic aneurysm repair 576f
Aortic arch
level of 44f
Aortocaval region lymph nodes 67f
Appendiceal abscess 206f, 208f
Appendiceal defects 211
Appendiceal intussusception
incomplete 211
types of 211
Appendiceal mass 202, 204f
Appendiceal stump 211
Appendiceal wall 199
Appendicitis 201t, 205
pathophysiology, acute 199
Appendicoappendiceal intussusceptions 211
Appendicolith 201, 207f
Appendicular mass 200
Appendix
mucocele of 210, 210f
tuberculosis of 209
Arrhythmia 611
Arterial
embolization 311
occlusive ischemia 173t
phase 327
late 8, 13
Arteriography 134
Arterioportal fistula 607, 609f
Arterioportal shunt 285f, 615
occlusion of 613
Arteriovenous malformation 194
Aryepiglottic fold, left 30f
Ascaris lumbricoides 366
Ascites 239, 511, 596, 597f
causes of 511t
Ascitic fluid 514f, 517f
Asian Pacific Association for Study of Liver 240
Aspergillosis 226
Aspergillus fumigatus 554
Aspiration 27
pneumonitis 624
Asplenia 550
Atlanta classification 398, 399
Atrium, right 613f
Atrophy 379
of right lobe 227
Autoimmune 324, 419
hepatitis 367
pancreatitis 419, 427, 428f, 444
Azathioprine 398
B
Bacterial liver abscess 265
Balloon angioplasty 612
of stenosed ostium 612
Balloon catheter, angioplasty using 613
Balloon dilatation of
stenosis 616
stricture 614
Balloon enteroscopy, double 84
Balloon-occluded retrograde transvenous obliteration 195
Barcelona clinic liver cancer 243, 244, 289, 306
staging system 290, 326
Bariatric surgery 583
Barium
double contrast 2f
enema 121, 125f, 136f, 474f
double contrast 2, 144, 162
enteroclysis 88t, 107, 478
meal 143, 149f, 197f
double contrast 62, 121
procedures 3t
retention of 198f
studies 1, 22, 143, 198f
swallow 22, 28f, 33f, 35f, 39f, 42, 45f, 46f, 47f, 628f
Barrett's esophagus 35
Basal pressure, high 34f
B-cell lymphoma 110
diffuse large 103, 103t, 109
Beger's procedure 588, 590
Bile duct
adenoma 248
defects 386
epithelium 248
hamartomas 250
inflammatory disorders 385
lesions 280
stones, remove 386
Biliary
anatomy 328
catheters 390
cirrhosis 227
colic, suspected 359f
communication 273
complications 496
cystadenocarcinoma 294, 295
cystadenoma 248, 251, 252f
dilatation 379
drainage 385
complications of 393
external-internal 389f
duct hamartomas 250, 251
pathology 250
ducts 366f
injuries 587
obstruction 588
radicles 389f
dilatation of 293, 293f
stent in situ 443f
stenting 390, 391f
stricture 333f
benign 386
system
extrahepatic components of 365
intrahepatic components of 365
tract 494
inflammatory pathologies of 361
malignancies 372
tree 332, 353
inflammatory conditions of 362
malignant pathologies of 372
obstructed 386
Biliopathy, obstructive 353
Bilobar intrahepatic biliary dilatation 365f
Biloma 276
Bismuth-Corlette system 379
Bladder injury 499
Bleeding, postoperative 578
Blind pouch syndrome 585
Blood
bile collection of 511
flow 135
transfusions 223f
Blunt abdominal trauma 488
Bowel
adenocarcinoma, staging of small 92t
adenoma, small 85f
border of small 112
carcinogenesis, small 83
carcinoids 93
continuity, postrestoration of 577
disease, inflammatory 153, 194, 215
evaluation 10
gangrene 577, 578
ischemia
etiology 168t
types 168t
large 585
ligaments to
large 507, 508
small 505, 508
loop
small 12f, 470f, 479, 580
with ascites 172f
lymphoma, small 109t
mass 127f
mesentery, small 507, 508
necrosis 410
obstruction
mechanical 580
postoperative 579
with enteroliths, small 148f
perforation 478
small 584
tuberculosis, small 146
tumors
diagnosis of small 83
number of small 83
small 83, 83t
wall
contrast enhancement 155
discontinuity 499
enhancement, abnormal 500
stenosis of 158
thickening of 155, 501
Brain death, donation after 333
Breast, carcinoma of 318f
Brucellosis 226
Brunner's gland adenomas 77
Budd-Chiari syndrome 336, 338, 341, 342, 480, 607, 611, 612
acute 337f
chronic 337f
management of 345
Bulky cervical lymphadenopathy 564f
Bull's eye lesion 70
Burkitt's lymphoma 103t, 107, 108, 538f
C
Cadaveric liver transplantation 332f
Calcific pancreatitis, chronic 388f
Calcinosis 367
Campylobacter jejuni 103
Cancers, infiltrative 62
Candida 36, 37
Candida albicans 36, 554
Candida esophagitis 36, 37f
Capsular retraction 252
Carbohydrate antigen 90
Carbon dioxide 186
angiography 186
Carcinoembryonic antigen 90, 119, 463
Carcinoid 95t, 212, 583
syndrome 93
tumors 92
Carcinoma 373, 374
ascending colon 575f
distal stomach 576f
early stage 51
gallbladder 13f, 163f, 389, 394f, 581f
Cardia 24
Cardiac failure 611
Cardiogenic shock 172f
Catarrhal stage 202
Caustic esophagitis 38, 39f
Caustic injury 38
Cavernous hemangioma, large 320f
Cavitatory mass lesion, large 136f
Cavoatrial junction 342f
Cecal bar sign 206
Cecum, pulled up 147f
Celiac artery 448f
angiogram 186f, 189f, 192f
Celiac axis 9, 166
angiogram 311f
injection 18f
Celiac disease, refractory 107
Celiac trunk 327f, 448f
Cell carcinoma
small 47
spindle 47
Cell of origin 248
Centro-centrizonal fibrosis 337f
Cervical
lymph node 30
osteophytes, enlarged 53
spine 54f
Web-Plummer-Vinson syndrome 23
Chemical ablation 307, 314
Chemotherapeutic drug 310f
Chemotherapy-induced cholangitis 366
Chest pain 583
Child-Pugh classification 235t
Cholangiocarcinoma 293, 293f, 294f, 365, 372, 377380, 383, 392f
Cholangiogram 392f
Cholangiographic abnormalities 364
Cholangiography, direct 358
Cholangitis 606
abscess, small 364f
ascending 366, 366f
etiology of 385
Cholecystectomy 581f
open 580
Cholecystitis
acute 361, 362f, 473, 474f
on chronic 362f
chronic 361, 361f
Cholecystoenteric fistula 361
Choledocolithiasis 13, 354f
Cholelithiasis 474f
Cholestatic diseases 324
Chondrocalcinosis 221, 224
Chronic illnesses 215
Cirrhosis 215, 216, 224, 226, 227, 232, 234t, 235239, 241, 244, 245, 284f, 324
causes of 233t
complications of 239
diagnosis of 234
of liver 602
treatment of 243
types of 233
with regenerative nodule 229f
Cirrhotic liver 238, 241f, 283f
Claustrophobia 208
Clonorchis sinensis 366
Clostridium difficile 483
Cluster sign 266, 267, 267f, 275, 279
Cobblestone 37
Colitis, diversion 585
Collapsed jejunum 624
Colon 412f
cancer 125f
carcinoma of 299f
Colonic adenocarcinoma 212, 536f
Colonic distension 12
Colonic diverticula 193
Colonic injury 500
Colonic ischemia 166, 177
Colonic stents 631
Colonic tuberculosis 147
Colonic ulcers 194
Colorectal cancer
screening for 120
staging 135
Colorectal stenting 622, 631
Colorectal tumors 117
Comb sign 158, 159f
Common bile duct 13f, 328, 354f, 357f, 362, 367, 375, 386, 419, 442f, 459, 465f
Common cystic tumors 456
Common hepatic
artery 18f, 166, 446, 448f
duct 328, 367
Computed tomography technique 204, 487
Congenital
cyst 550, 553f
esophageal stenosis 36
hemangioma 262
hepatic fibrosis 194, 248
transferrin deficiency 221
Conglomerate caseous lymphadenopathy 517f
Conglomerate lymph nodal mass 137f
Contrast-enhanced
computed tomography 99, 282, 386, 403, 486
magnetic resonance 282
ultrasound 7, 240, 486, 544
Contusion 491
Corkscrew esophagus 32f
Coronal maximum intensity projection 9f
Coronary
ligaments 508
vein, angiogram of 617
Corrosive esophagitis 38
Coughing, terms of 27
Cowden's disease 87, 89, 138
Coxsackie B virus 398
Crampy abdominal pain 93
Cricopharyngeal bar 23, 28
Cricopharyngeus muscle 28f
Crohn's disease 143, 153, 154, 201, 223
activity index 154
classification of 154t
Cronkhite-Canada syndrome 88, 140
Cryoablation 310
Cryptococcosis 226
Cryptococcus neoformans 554
Cryptosporidium parvum 363
Cyst
false 552
formation of multiple small 456f
partial calcification of 554
peribiliary 250
Cystadenocarcinoma 212, 381
Cystic bile duct neoplasms, malignant 381
Cystic endocrine tumors 462
Cystic focal lesions, multiple 136f
Cystic lesion
classification of 456f
large 295
multiloculated 264f
multiple 460f
of spleen 550
Cystic mesothelioma 526
Cystic metastases 462
Cystic pancreatic tumors 445, 455, 462
classification of 456t
Cystic teratoma 462
Cystic tumors, rare 456
Cysts 250f
Cytomegalovirus 36
Cytoreductive surgery 526
D
Daughter cysts 271f, 554
multiple 272f
De novo hepatocarcinogenesis 281
Desmoid tumor 526, 529, 529f
multiple 83
Desmoplastic
round cell tumor 528f
small round cell tumor 526, 528
Diaphragmatic injury 493, 587
Diffusion coefficient 436
Digital subtraction angiography 167f, 184, 414, 487
Diseases, miscellaneous 162
Distended appendiceal lumen 202f
Diverticulitis 481
Doppler ultrasound images 177f
Dorsal esophagus, upper 45f
Dorsal mesentery 505
Dorsal vertebrae, anterior wedging of 224
Double duct sign 439
Double target sign 267f
Drainage catheter, internal-external 392f
Dropped gallstones 588
Drugs 215
Dual energy computed tomography 281, 416
Duct pancreatitis
large 418
small 418
Duct syndrome, disconnected 408
Ductal system
left 392f
right 389f, 392f
Duodenal
adenocarcinoma 78
carcinoids 70
focal lesions 76
gist 73
ileus 472
intramural pseudocyst 424f
stent 630
stenting, technique of 630f
tuberculosis 150, 150f
tumors 76
benign 77
malignant 77
ulcer 470f
wall, medial 446f
Duodenum 412f, 507
opacification of 191f
parts of 465f
surgeries of 583
Dyslipidemia 232
Dysphagia 55
causes of 21, 23t
etiology of 22t
evaluation of 22
mechanical 21
pathogenesis of 21
symptoms of 22t
Dysplastic nodules 229
Dyspnea 583
E
Eastern Cooperative Oncology Group 326
Ebstein-Barr virus 103, 107
Echinococcal cyst 552
Echinococcus granulosus 269
Echinococcus multilocularis 274
Echo train length 14
Echoes, internal 476
Echogenic liver 241f
Ectopic varices 600, 601, 601t
Edema 234, 575f
Emergency laparotomy 77
Emphysematous cholecystitis 475, 475f
Empyema 475
Endocrine 239
neoplasia, multiple 71, 462
Endocyst, detachment of 554
Endoexoenteric form 104, 106
Endoluminal tumors 72
Endorectal ultrasound 125
Endoscopic
biopsy 150
placement 629
retrograde cholangiopancreatography 357, 372, 385, 435, 498
techniques 433
ultrasound 26, 41, 50, 358, 359, 422, 432, 435, 455
Entamoeba histolytica 267
Enterochromaffin 92
Enterocolic fistula 160f
Enterocutaneous fistula 579
technique of 632f
Enteropathy associated T-cell lymphoma 103, 103t
Eosinophilic
cholangitis 369, 370f
esophagitis 40
gastroenteritis 163
Epigastric pain 399
Epigastrium, compression of 354
Epiploic appendagitis 522f
Epithelial polyps 57
Epithelial tumors of colon 135
Epithelioid hemangioendothelioma 280, 296, 297f
Escherichia coli 554
Esophageal
cancer 43, 48, 50
staging of 48, 48f
system for 48t
dysmotility 367
dysphagia 22
mechanical 23
structural 35
fistula, malignant 625
GIST 42, 42t
leiomyomas 42
manometry 22, 25, 26f, 34f
motility disorder 31, 31f
neoplasms 41
benign 41
malignant 43
perforation 625
peristalsis 34f
pressure topography 26f
ring, lower 36
scintigraphy 26
spasm, diffuse 31
sphincter
lower 31, 33
patulous, lower 35f
upper 29
stage 21
stent evaluation 629
stenting 622, 624, 628
preparation of 627f
technique of 628f
strictures, benign 625
surgeries 582
tuberculosis 150
varices 601
Esophagitis 35
Esophagogastric junction 45f
Esophagus 24, 27, 38f, 44f, 54f
dilated 33f, 35f
distal 33f
lower 44f, 51
end 47f, 602
mid 45f
midportion of 44f
upper 45f, 51
Ethanol acid ablation 307
European Association for Study of Liver 240
European Gastrointestinal Lymphoma Study 110
Exophytic hepatic lesion hypointense 255
Exophytic tumors 75
Extrahepatic
biliary ducts, dilatation of 363
portal vein obstruction 544, 603, 604
shunt 600
Extraluminal mottled gas 472
Extranodal marginal zone B-cell lymphoma 68, 103, 103t, 109
F
Facial trichilemmomas 87
Falciform ligament 506f, 507, 508
Familial adenomatous polyposis 85, 87, 89, 118, 122f, 529, 529f
syndrome 138
Fasciola hepatica 225
Fast spin echo 402
Fat
attenuation
pericolic oval lesion of 522f
values 265
density 405
fraction 218
proliferation 157f
Fat-suppressed 433
Fatty infiltration 217f, 224, 276
Fatty liver 215, 216, 216f, 217f, 219, 220f
echogenicity of 216f
parenchyma 220f
Fatty replacement of pancreas 423f
Fatty transformation of pancreas 429f
Fecal immunochemical test 120
Fecal occult blood test 121
Fecal tagging 12
Ferumoxide 254
Fetal lobulations 549f
Fever 577f, 624
abdominal 367f
high-grade 577
Fibrinous septae 516f
Fibrofatty proliferation 160
Fibrolamellar carcinoma 257, 291, 292f
Fibroma 248
Fibrosis 157, 239
Fibrostenotic disease 161t
Fibrotic stage, chronic 157
Fibrotic stricture in tuberculosis 148f
Fibrovascular polyp 42
Fibrovascular septae 85
Fine needle aspiration 6
cytology 544, 565
Fistulas 159
Floating membranes 270
Fluorine 18-labeled deoxyglucose 134
Fluorodeoxyglucose 535
Fluoroscopic placement 629
Fluoroscopic spot images 623f
Focal
confluent fibrosis 226
diaphragmatic
discontinuity 501
thickening 501
fat sparing 220f
gastric lesions mimicking tumor 74t, 75
hypodense
lesion in liver 152f
mass lesion 566f
liver lesions, diagnosis of 301
nodular hyperplasia 248, 254, 256, 257
pathogenesis 254
pathology 256
Follicular lymphoma 103t
Foramen of Winslow 513
Foreign bodies 51
Frey's procedure 589
Frosted liver 275
Fulminant hepatic failure 324
Fundic gland polyps 57, 58
Fungal hepatic abscesses 269
G
Gadoxetic acid 289
Gallbladder 236f, 353, 473, 474
cancer 372
classification for 373t
carcinoma 372, 373, 374, 376, 376f, 377, 383
empyema of 395f
fossa 276, 576f
mass 373
with cholelithiasis 355f
inflammatory conditions of 361
lumen of 395f
lumen, mass replacing 374
malignancy 361
neck 375
neoplasms, malignant 377
perforation 475, 475f
wall 474f, 475f
with intramural air foci 475f
Gallstone 407
disease 588f
Gamma glutamyl transpeptidase 224
Gamna Gandy bodies 568
Ganglioneuromas 213
Ganglioneuromatosis 213
Gangrenous cholecystitis 475
Gardner's syndrome 83, 88, 89
Gastrectomy 590
distal 576
Gastroesophageal reflux disease 21
Gastric
adenocarcinomas 59
artery 18f, 185
angiogram 189f
cancer 59, 60, 60t, 61, 63
staging of 60, 60t, 65
carcinoid 71
carcinoma 584
recurrent 66f
duplication cyst 76
folds 62
fundus 74
carcinoma of 21
GIST 578
lesions 61
lipomas 73
lymphoma 67, 69
mucosa 58
neoplasms, malignant 59
polyps 57
tuberculosis 150
ulcer 62
varices 601, 617
vein, left 606f
wall 63
Gastrinoma 70
triangle region 465f
Gastrocolic ligament 507
Gastroduodenal
artery 9, 18f, 186f, 414
spasm of 186f
ligament 507
stenting 622, 629
strictures, benign 629
Gastroesophageal
junction 1f, 24, 48
reflux disease 26, 35, 40, 43
varices 234, 600, 601t, 602
Gastrohepatic ligament 507, 536f
Gastrointestinal 478
bleeding 212
carcinoids 93
endoscopy, upper 22, 26, 182
hemorrhage 181, 187, 239
lower 181, 187, 189
massive 189f
upper 181, 187, 189, 317f
lymphoma 103t
stromal tumors 41, 42, 59, 71, 76, 83t, 85, 89, 95101, 111, 117, 136, 538, 539
tract 181
tuberculosis 146
tumors 446
Gastrojejunostomy 584
Gastrophrenic ligament 508
Gastrorenal shunt 603f
Gastrospenic ligament 507
Gastrostomy 623f
tube 623
Gaucher's disease 568
Germinal layer, inner 552
Giant hemangiomas 253
Gianturco-Z stent 626
Glomus tumor 75
Graft-to-recipient body weight ratio 325
Granulocyte epithelial lesions 427
Granulomatous diseases 215, 224, 225f
H
Hamartoma 562
syndrome, multiple 138
Hamartomatous polyps 57, 59
Head
and neck surgery 23
of pancreas 356, 476, 498f
Helicobacter pylori 58, 68
Hemangioendothelioma 296
Hemangioma 75, 85, 194, 248, 251, 252, 253f, 262f, 558
medium size 253
pathology 252
suggestive of 216f
Hematemesis 186f
Hematogenous
metastases 119
spread 533
Hematoma 276, 491, 501f
Hemicolectomy 575f, 579
Hemobilia 189, 190f, 495, 496f, 589
Hemochromatosis 215, 221223, 224f, 568
Wilson disease 324
Hemodynamic status 488
Hemolytic anemia 570f
Hemoperitoneum 171f, 488, 490f, 561f
detection of 485
Hemorrhage 73, 287f, 495, 624
Hemorrhagic cholecystitis 475
Hemosiderosis 215, 224f
Hemothorax 501
Henoch-Schonlein purpura 201
Hepatectomy 587
Hepatic
adenoma 257, 259, 321f
pathogenesis 257
pathology 259
alveolar echinococcosis 274
angiogram 191f
angiography 190f
arterial infusion 319
artery 9, 18, 285f, 310f, 311f, 330, 589
aneurysm 190f
aneurysm, large 191f
angiogram 186f, 190f, 320f
embolization 496
injection 497
left 327f
middle 191f
pseudoaneurysm 495
right 311f, 327f, 609f
thrombosis 330, 332f
cysts 248, 249, 250f, 251
pathology 248
duct 13f, 379
right anterior 329
right posterior 329
encephalopathy 226
evaluation 9t
fascioliasis 225
fibrosis 232
fissure 227
flexure 577f
foregut cyst, ciliated 250
hemangiomas 216
hydatids 272f
lymphoma, primary 302f
metastases 91
parenchyma 222
sarcoidosis 275
schistosomiasis 275
steatosis 215
tuberculosis 274
vein 5f, 6f, 215, 318f, 328, 331f, 338, 339f, 343f, 344f, 349f, 610
angioplasty 612
left 325
middle 325, 330f
nonopacification of 339f
patency of 595
pressure gradient 600
stenting 316, 612
venogram 612
venous
anatomy 328f
outflow obstruction 243
pressure 600
Hepatitis 215, 324
acute 224
B virus 232
C virus 232
chronic 221
active 224
severe acute 219
Hepatobiliary surgeries 585
Hepatoblastoma 294, 296f, 324
Hepatocellular adenoma 248, 257, 259
pathogenesis 257
pathology 259
Hepatocellular carcinoma 226, 227, 230, 232, 239, 257, 280, 283f, 290, 305, 306, 324, 377, 597
Hepatocellular hyperplasia 248
Hepatocellular tumors 280
Hepatocholangiocarcinoma 293, 295f
Hepatocyte 248
specific agents 254, 257
Hepatoduodenal ligament 507
Hepatolenticular 224
Hepatopulmonary syndrome 593
Hepatorenal
pouch 486f
syndrome 226, 593
Hepatosplenic TB 152
Hepotocellular carcinoma 281
Hernia
internal 512, 513t
type of 513
Heteroechoic lesions, multiple 127f, 298f
Heterogeneous 221
echotexture
of liver 364f
on ultrasound 230
mass 529f
large 130f
lobulated 294f
peritoneal masses 539f
soft tissue mass 523f
Heterotopic cells 248
High-intensity focused ultrasound 310
Hilar cholangiocarcinoma 378
Hilar obstruction 392f
Hodgkin's lymphoma 103t, 223, 563, 564f
Homogeneous 222
Honeycomb pattern 554
Hounsfield unit 217, 544
Human immunodeficiency virus 324, 362, 554
Hydatid cyst 271f, 273f, 555f
complications of 272
structure of 269
Hydatid disease 269
Hydropneumothorax 268
Hydroxyiminodiacetic acid 358
Hypercalcemia 398
Hypercoagulable states 606
Hyperechoic submucosa 202
Hypereosinophilic syndrome 370f
Hyperintense 257
fluid collection 208f
lesion, small 289f
nodule, multiple small 343f
Hyperintensity of nodules 343f
Hyperlipidemia 233, 398
Hypermotility 159
Hyperplastic polyps 57, 58
Hypertension, detecting portal 596
Hyperthermic intraperitoneal chemotherapy 526
Hypertrophic 146
Hypertrophied left lobe 321f
Hypervascular
focal lesions, multiple 284f
metastases 299f, 319f
Hypoalbuminemia 511
Hypoattenuating lesion, small 265f
Hypochondrial pain 582
Hypodense 225
cystic lesions, multiple 519f
cysts, multiple 249f
lesion 225f, 267f
in spleen 153f
multiple 299f
liver, diffusely 220f
mass 297f
lesion 439f
multiple 538f
nodules, multiple 569f
Hypodensity, central 277f
Hypoechoic
hemangioma 216f
lesions 249f
multiple 265f
masses 299
Hypoenhancing lesion, ill-defined 424f
Hypointense lesions 557f
Hypointense mass 288f, 441f
lesion, large 287f
Hypokalemia 465
Hypomotility 159
Hypoperfusion
complex 490t
state 490
Hypopharynx 24f
Hypovascular metastases 299f
I
Iatrogenic trauma 511
Idiopathic cirrhosis 232
Idiopathic duct centric pancreatitis 427
Ileal adenoma 194f
Ileal lipoma 87f
Ileal pouch-anal anastomoses 585
Ileal stricture, distal 478
Ileocecal junction 148f, 156f
Ileocecal tuberculosis 147f, 149f
Ileocecal valve 123, 197f
Ileocolic intussusception 471f
Ileum, distal 158f
Iliac fossa 204f, 206f, 210f
Immunoscintigraphy 134
Impulse elastography 6
Incisional hernia 581
Infantile hemangioendothelioma 248
Infantile hepatic hemangioma 262, 264
pathogenesis 262
pathology 263
Infections, chronic 223
Infectious esophagitis 36
Infective endocarditis 480
Infective peritonitis 511
Inflammation predominates, chronic 521
Inflammatory
diseases, chronic 216
esophagitis 38
fibroid polyp 86
myofibroblastic
pseudotumor 526, 530
tumor 530f
processes, secondary 518
pseudotumor 75, 277, 277f, 563
Inframesocolic space, right 511
Inhibitory innervation, disorders of 23
Injury grading system 494
Injury, abdominal 492, 496
Insonation, angle of 595
Intensity projection, maximum 11, 13, 184, 356, 545
Intensity ratio, signal 222
Intensity, signal 27
International Union Against Cancer 120
Interstitial edematous pancreatitis 401
Intestinal
disease, immunoproliferative small 111
injury, diagnosis of 499
obstruction 470, 477, 520f
pneumatosis 472
Intra-abdominal abscess 476
Intra-arterial procedures 305, 310
Intraductal
papillary mucinous neoplasm 456, 459, 459t
ultrasound 359
Intraesophageal pH monitoring 26
Intrahepatic
bile ducts 357, 496f
biliary ducts, dilatation of 363
biliary radicals 442f
dilated 354f, 357f
normal 13f
cholangiocarcinoma 293, 377, 378
duct, dilatation of 356f
portal hypertension 602
portosystemic shunt, direct 611
veno-venous collaterals 598, 599f
Intraluminal brachytherapy 393, 394f
Intraluminal polyp 375f
Intramural pseudodiverticulosis 40, 40f
Intraoperative cholangiography 329
Intraperitoneal rupture of urinary bladder 493
Intrasplenic hypodense lesion 562f
Intratumoral arterioportal shunts 317f
Intravenous
cholangiography 355, 356
contrast injection 11
Intravoxel incoherent motion 436
Intrinsic narrowing 23
Iodinated contrast material 327
Irreversible electroporation 310
Ischemia 501
Ischemic bowel disease 166, 168t
pathophysiology of 168
Ischemic enterocolitis 166
Isointense mass, ill-defined small 440f
Issue transition projections 171
J
Jaundice 359f
abdominal 367f
obstructive 359, 388f390f, 588f
Jejunal arteriovenous malformation 194f
Jejunal gastrointestinal stromal tumor 102
Jejunocolic anastomosis 577
Jejunoileitis, chronic 107
Jejuno-jejunal intussusception 88t
Jejunostomy 577
Juvenile polyposis 59, 88, 140
syndrome 59
K
Kaposi's sarcoma 70, 111, 525
Kasabach-Merritt syndrome 263
Kidney 412f
left 482
right 470f
Klatskin's tumor 378
Klippel-Trénaunay syndrome 75
Kulchitsky cell 92
Kupffer cells 257
L
Lacerations, multiple 495f
Laparoscopic cholecystectomy 582, 587, 588f, 589
Laryngeal penetration 27
Laser ablation 310
Leiomyoma 41, 41f, 42t, 70, 74, 85, 248, 265
Leiomyomatosis pertonealis disseminate 531
Leiomyosarcoma 46, 46f, 74, 111, 136f
jejunum 111
Leishmaniasis 226
Leptospirosis 226
Lesions
miscellaneous 276
Leukemia 230
Ligaments
broad 509
round 509
Light bulb appearance 253255
Lipase 398
Lipiodol cast formation 618f
Lipiodol defect 312f
Lipoma 77, 85, 248
Lipomatous tumors 264
Liposarcoma 74
Littoral cell angioma 563
Liver 152f, 222, 412f, 443f, 494
abscess 191f, 267f
pericardial rupture of 270f
attenuation index 217, 330f
benign
focal lesions of 248
tumors of 264
cancer staging system 306
chronic disease of 226
cirrhosis 232
changes of 225f
nodules in 228t
cysts 249f
multiple simple 250f
disease
chronic 7f, 10f, 217f, 229, 291
diffuse 215, 602
end stage 234, 324
malignant diffuse 230
donor 327f
echogenicity 220f
fat fraction 218f
fibrosis, estimation of 239
fluke 225
hematoma, large subcapsular 495f
imaging reporting 291, 326
injury 493
type of 494
iron
concentration 222
content 222
ischemia 611
laceration, linear 492f
left lobe of 321f
lesions, multiple 443f
ligaments of 505, 508
lobes of 313f
malignant focal lesions of 280
margins 537f
metastasis 71, 134f
single 318f
MRI of 13
parenchyma 222f, 264f, 329, 342, 349f, 365, 497
signal drop of 219f
signal intensity of 223f
peripheral 344f
resection, partial 11f
right lobe of 225f, 253f, 317f, 318, 320f, 321f
segments of 299f
signal intensity of 223f
transplantation 324, 324t, 333f
donor 326
types of 325
tumors
classification of benign 248
interventions for 305t
treatment of benign 319
ultrasonography evaluation of 2
volumetry 329f
Living donor liver transplantation 306, 325, 327
Lobe
hepatocellular carcinoma, right 317f
liver donor, right 333f
Locoregional lymph node 51, 134f, 135f
Lumen-carcinoma 44f
Lump in throat 21
Lump, abdominal 108
Lung carcinoma 299
Lymph nodal tuberculosis 152, 152f, 153f
Lymph node 68, 131f
enlarged 147f
multiple 557f
number of positive 91
palpable superficial 68
regional 60, 66, 120
Lymphadenopathy 257
reactive 160
Lymphangioma 248, 462, 463f, 562
Lymphatic
extension 533
infiltration-varicoid, mucosa with 44f
lymphangioma 531
malformations 531
spread 119
Lymphoid tissue, mucosa associated 68
Lymphoma 46, 68, 70, 78, 102, 109, 230, 301, 525, 525f, 563
extranodal site of 68
ileum 105
jejunum 105
of appendix 212
small bowel 104f, 106
Lymphomatous involvement 445
Lynch syndrome 83
M
Macrocystic
lesion with
fewer 456
larger 456
neoplasm 459f
serous cystadenoma 458f
Macronodular form 275
Macroregenerative nodules 248
Maffucci syndrome 75
Magnetic resonance
angiography 187
cholangiopancreatography 12, 326, 329, 359, 372, 402
colonography 134
elastography 238
enterography 16
Malena 589
Mantle cell lymphoma 103, 103t
Massive splenomegaly 225f
Meckel's diverticulitis 193, 201
Melanoma
malignant 70
Mesenchymal
cells 248
hamartoma 248, 262, 263f, 264f, 278
polyps 57, 59
tumors
benign 526
malignant 280, 526
miscellaneous 531
Mesenteric adenitis, primary 524
Mesenteric artery
angiogram
inferior 194f
superior 194f, 195f
branch of
inferior 167
superior 167f, 172
inferior 17, 166, 167, 167f
obstruction, superior 168f
superior 9, 17, 166, 167, 446, 478, 497, 609f
thromboembolism, superior 169
Mesenteric carcinoid 539
Mesenteric cyst 531f
Mesenteric edema 159, 518
Mesenteric fibromatosis 526, 529
Mesenteric hematoma 493, 501
Mesenteric infiltration 500, 501
Mesenteric injury 501f
Mesenteric invasive form 104, 106
Mesenteric ischemia 166, 173t, 472, 478, 479
acute 169
chronic 175, 175f, 176t, 178f
treatment of acute 174
Mesenteric lipodystrophy 521
Mesenteric lymph nodes, small 521f
Mesenteric lymphadenopathy 523
causes of 523t
Mesenteric lymphangioma 532f
Mesenteric panniculitis 521
Mesenteric vein
inferior 593
superior 407, 593, 609f
Mesenteric vessels
beaded appearance of 501
superior 438f
Mesentric adenitis 524f
Mesentric lymphangioma 532f
Mesoappendix 197
Mesocaval shunt revision 616
Mesorectal
excision 133
fascia 133f, 139f
Mesothelioma, primary malignant 526
Metabolic
diseases 324
disturbances 234
Metallic stent 390, 390f, 626, 630
Metastases 48, 60, 301f, 373, 377, 445, 565
distant 61, 120
small bowel 112, 113f
Metastatic disease 70
of liver, treatment of 316
secondary malignancies 297
Metastatic lesions 95
Metastatic lymph nodes, number of 60
Metastatic necrotic peripancreatic lymph node 376f
Metastatic neoplasms 111
Metastatic tumors 57
Micronodular form 275
Microwave ablation 310
Monoclonal antibodies 134
Morrison's pouch 470f, 536f
Motility 31
abnormal 159
disorder
primary 31
secondary 35
Motor dysphagia 21
Motor esophageal dysphagia 23
Motor oropharyngeal dysphagia 23
Mucinous
adenocarcinoma 212, 537f
cystadenoma 212
large 424f
cystic neoplasm 456458, 458f, 459f
Mucosal folds, loss of 62
Multicentric carcinoma 45f
Multicystic mesothelioma 527
Multidetector computed tomography 9, 143, 283, 326, 327, 587
Multilocular cystic mass 252f
Multilocular inclusion cyst 527
Multiloculated mass 212, 273f
Multiphase acquisition 13
Multiseptated cystic mass 527f
Muscles, diseases of smooth 23
Muscularis propria 126f, 139f
Musculoskeletal system 502
Mycobacterium avium complex 362
Mycobacterium tuberculosis 146, 554
Mycotic pseudoaneurysm 480
Myelolipoma 248
Myoepithelial hamartoma 76
Myofibroblastic tumor 75
Myxoglobulosis 210
N
Nasogastric tube 623f
detection of 501
Nasopharyngeal-endoscopy 22
Nasopharyngoscopy 25
National comprehensive cancer network 446
N-butyl cyanoacrylate 413
Neck and body of pancreas, junction of 465
Necrosis 73
central 74
Necrotic collection, acute 400, 401, 408
Necrotic mass, large 528f
Necrotizing pancreatitis 401
Neoplasms 511, 606
benign 558
malignant 563
of appendix, primary 211t
of bile ducts, malignant 382
Neoplastic
lymphadenopathy 525
processes 523
Neural tumors 75
Neuroendocrine tumors 17, 92, 213, 445, 539
of pancreas 455
Neurofibromatosis type 1 96
Neurogenic tumor 86
of stomach 74
Neutropenic
colitis 483f
Nodular filling defects, diffuse 44f
Nodular form 68
Nodular greater omentum 535f
Nodular regenerative hyperplasia 248, 260, 278, 291
clinical features 262
pathogenesis 260
Nodules, multiple 104
Nonalcoholic
fatty liver 215
disease 232
steatohepatitis 215, 232
Noncirrhotic liver 299
Noncirrhotic portal
fibrosis 603
hypertension 603
causes of 604t
Non-enhancing mucin globules 461f
Nonepithelial tumors of colon 136
Nonfunctioning primitive neuroectodermal tumor 464f
Non-Hodgkin's lymphoma 102, 525f, 563
Noninvasive intraepithelial neoplasia 58
Nonocclusive mesenteric ischemia 169
Nonsteroidal anti-inflammatory drugs 162
enteropathy 162
Nonthermal ablation 310
Nonvascular complications 407
Nonvascular procedures 412
Nuclear imaging 17, 65
O
Octreotide scintigraphy 17
Omental
bursa 511
cake appearance 526f
caking 533
infarction 482, 522, 523f
thickening 515
Omentum 505
Organ
abdominal 511
injury scale 493t, 494t, 497t
Organic anionic transport polypeptide 289
Oriental cholangiohepatitis 366, 367f
Oropharyngeal abnormalities
functional 27
structural 28
Oropharyngeal airway 31f
Oropharyngeal dysphagia 22
mechanical 23
Oropharyngeal stage 20
Oropharyngeal tumor 23, 29
Osler-Rendu-Weber disease 75
Osteochondritis dissecans 224
Osteomalacia 224
Ovarian
malignancy 535f
mucinous adenocarcinoma 534f
torsion 481f
vein thrombosis 481
Ovary
carcinoma 565f
enlarged right 481f
normal left 481f
P
Pain 624
abdomen 523f, 577f
Pancreas 222, 434f, 476, 496
carcinoma head of 355, 388f, 390f
neck of 499f
partial transection of 499f
signal intensity of 224f
tail of 404
Pancreatectomy
central 589
distal 578, 579f, 589, 590
Pancreatic adenocarcinoma 430
Pancreatic cancer 441f444f, 446f
imaging 432, 433
staging of 446
variants 440
Pancreatic carcinoma 357f, 435f, 438t, 439f, 443f, 447f, 449f, 450f, 451t
Pancreatic divisum 421f, 426f
Pancreatic duct 13f, 192f, 357f, 498
dilation, mild 590
involvement of 493
Pancreatic ductal calculi, large 423f
Pancreatic fistula 590
Pancreatic head
mass 435f
small 447f
neck region 440f
region of 445f
Pancreatic injuries, detection of 496
Pancreatic malignancy 451f
Pancreatic mass evaluation 437f
Pancreatic neck, necrosis of 409f
Pancreatic neuroendocrine tumors 463, 463t
Pancreatic parenchyma 551f
Pancreatic pathology
evaluation of 9
MRI of 15
Pancreatic phase 11
Pancreatic protocol 13
Pancreatic rest cells 70
Pancreatic surgery 588
group of 452
Pancreatic tail 462, 463
cystic mass in 459f
region of 462f
Pancreatic transection 493
Pancreatic tuberculosis 153
Pancreatico-duodenectomy 78
Pancreatitis 186f, 189, 217f
acute 192f, 398, 399, 401t, 402t, 443f, 475
calcifying chronic 419
chronic 184f, 418, 422f426f, 430, 444, 445f
calcifying 420f
classification of chronic 418
complications of acute 407t
groove 428, 429f, 444
in cystic fibrosis, chronic 428, 429f
mass forming chronic 435
obstructive chronic 419
pathophysiology of acute 399f
phases of acute 400
postoperative 590
severe 401
acute 419
types of chronic 427
Papillary
mesothelioma 529
serous carcinoma 528f
stenosis 363
Paracolic spaces 511
Paraduodenal
hernia 513f
Paraesophageal 602
varices 601
Paragangliomas 213
Paralysis 159
Pararectal space 511
Paraspinal muscle 222
Parastomal
hernia, small 581
hernial sac, large 581
Paraumbilical veins 602f
Parenchymal
atrophy 227
branches 613
echogenicity 215, 226
hematoma, rupture of 495f
infiltrative disorders 216
tract 610
Parietal peritoneum 505
Pediatric liver tumors 262
Peliosis 563
hepatis 276
Pelvic
disease 480
inflammatory disease 468, 481
pain, chronic 527f
peritoneal spaces 511
Pelvis 8, 533f
ligaments of 507, 509
Percutaneous ablative
techniques 305
therapy 306
Percutaneous acetic acid injection 307
Percutaneous alcohol injection 307f
Percutaneous cholecystostomy 393, 395f
Percutaneous enterocutaneous fistula closure 622, 632
Percutaneous ethanal injection 306, 307
Percutaneous gastrostomy 622
Percutaneous hepatography 339f
Percutaneous jejunostomy 622, 624
technique of 625f
Percutaneous stent placement 347f
Percutaneous transgastric jejunostomy 622
Percutaneous transhepatic
biliary drainage 386, 393
cholangiography 358, 385
cholangioplasty 393
portogram 617
puncture 350f
variceal embolization 614, 617
Perforation peritonitis 514f
Periampullary carcinoma 380, 381f, 382, 382f, 398
Perianal fistulas 160f
Pericatheter seepage 624
Pericholecystic fluid 474
Perigastric nodal 71
Perihilar cholangiocarcinoma 380, 380f, 381
Perilesional edema 267f, 269
Perinephric
hematoma 171
region, gas in 472
Peripancreatic
fat stranding 403
fluid 476
collection, acute 400, 401, 403, 407
inflammation 192f
Periportal fluid tracking 495f
Perirectal lymph node 133f
Perisplenic
fluid 556f
hematoma 561f
lymph nodes 545f
Peritoneal
abscess 514
adenomucinosis, disseminated 536
carcinomatosis 507f, 533, 534f, 535f
cavity 273f, 505
deposits 536f
multiple 376f
fluid 500
dynamics 511
hydatid cysts, disseminated 519f
hydatidosis 273, 273f, 518
inclusion cyst 527, 527f
infections 512
leiomyomatosis, diffuse 531
ligaments 505, 510, 510t
lymphoma, primary 526
lymphomatosis 537
malignant mesothelioma 525
mesothelioma 526f
metastases 443f
mucinous carcinomatosis 536
neoplasms
primary 525
secondary 532
nodules, small 444f
sarcomatosis 538
seeding 120, 273
serous carcinoma 526, 528
tuberculosis 151, 516f518f
Peritoneum, anatomy of 505
Peritonitis 512, 624
Perivaterian carcinoma 78
Peutz-Jeghers syndrome 59, 8789, 138
Pharyngeal diverticula 29
Pharyngeal foreign bodies 30
Pharyngomanometry 22
Pharynx 24, 27
Phrenicocolic ligament 509
Pigtail catheter 394f
Pill esophagitis 39
Plasmacytoma 75
Plastic biliary stent, single 390f
Pleural effusion 501
Plummer-Vinson syndrome 28
Pneumatosis intestinalis 170, 501
Pneumobilia 589
Pneumoperitoneum 491, 499, 500f, 512
Pneumothorax 501
Polycystic liver disease 248, 249
Polyethylene glycol solution 145
Polypoid
carcinomas 62
lesions, multiple 529f
mass 374
Polypoidal
cecal growth 131f
filling defects 44f
lesion 126f
mass 139f
lesion 128f
Polyposis syndromes 138
number of 86
Polyps
benign 84
multiple 122f
of inflammatory type, hyperpigmentation 88
Polysplenia 550, 552f
Polytetrafluoroethylene 345, 393
Porcelain gallbladder 372, 383
Portal hypertension 232, 237, 238, 593, 595, 596, 608, 609t
causes of 593, 593t, 609f
interventions in 609
signs of 600
Portal system, anatomy of 593
Portal vein 215, 285f, 328, 407, 616, 617
bifurcation of 5f
diameter 596
embolization 305, 316
main 587f, 605f
thrombosis of 286f, 590, 605
tumor thrombosis 313
Portal venous
anatomy 328f
branches 171f
phase 11, 13, 327
system 167
Portal-systemic encephalopathy 593
Portocaval shunts 221
Portomesenteric air 472
Portosystemic venous collaterals 596
Posthepatic causes 607
Post-necrosectomy pseudocyst 408
Potassium hydroxide 38
Preablation arterial phase 315f
Prehepatic causes 604
Premature osteoarthritis 224
Progressive disease 314
Progressive systemic sclerosis 32
Prominent cricopharyngeus muscle 28
Proteolytic enzymes 398
Proton
density fat fraction 218
pump inhibitor 58
Provocative angiography 186
Pseudoaneurysm 184f, 191f, 192f, 410, 411f, 414, 567f, 578
complete isolation of 615f
large 186f, 589
of gastroduodenal artery 615
Pseudocyst 552
Pseudodiverticulum formation 160
Pseudokidney sign 125f, 127f
Pseudomyxoma peritonei 212, 536, 537f
Puestow procedure 589
Pulse repetition frequency 595
Purulent peritonitis 514f
Puylaert's technique 201
Pyelonephritis 482
Pyogenic liver abscess 265, 266f, 267f
Pyrexia 166
Pyriform sinus 24f
R
Radiation
enteritis, acute 163f
exposure 415
hepatitis 221
Radiofrequency ablation 243, 290, 308
Radionuclide studies 182
Raynaud phenomenon 367
Rectosigmoid colon 2
Rectouterine
pouch 533f
space 511
Rectovesical 511
Rectum
carcinoma 586
distal 123
Refractory encephalopathy, shunts in 619
Regenerative nodule 290f
Renal
artery 9
contusion, right 171f
dysfunction 239
pelvic injury 493
vein
patency of left 595f
patent left 619f
Renal-Hemiazygous pathways 341
Resectable pancreatic cancer 447f
Respiration 595
Reticuloendothelial cells 223
Retinal pigment epithelium 140
Retractile mesenteritis 521
Retroanastomotic 513
Retrocecal appendicitis 205f
Retroperitoneal lymph nodes 525
Retroperitoneum 502
Retropharyngeal abscess 23, 29, 31f
Rheumatoid arthritis 223
Rib fractures, lower 501
Roux loop 589
Roux-en-Y
bowel 589
gastric bypass 584
S
Sarcoidosis 225, 568, 569f
Scaffolding’ technique 415
Schatzki ring 36
Schistosoma haematobium infection 275
Schistosoma japonicum 275
Schistosoma mansoni 275
Schistosomiasis 225
Schmorl's nodes 224
Schwannoma 74
Scintigraphy 546
Scleroderma 35, 35f
Sclerosed hemangiomas 252
Sclerosing cholangitis
causes of 365
Sclerosing peritonitis 520f
Sectoral hypertrophy 140
Sentinel clot sign 488, 490f
Sepsis 606, 611
Serohepatic tuberculosis 275
Serous cystadenoma 456, 457f, 457t
Sessile tumors, removal of large 85
Shear wave elastography 6, 237, 238, 280, 435
Sheet-like growth 533
Shock bowel 490
Shrunken liver 225f, 238
Shunt, disappearance of abnormal 615f
Sinuses 159
Sjögren's syndrome 367
Snake skin 37
Sodium 38
Soft tissue 472
density mass 206f
masses 100
Solid cystic mass 462f
lesion 534f
Solid hypoechoic mass lesion 438f
Solid papillary epithelial neoplasm 462f
Solid pseudopapillary neoplasm 461, 461t, 462f
Solitary enhancing nodule 238
Somatostatin receptor 17
scintigraphy 95
Sonographic anatomy 5
Sonographic hepatorenal index 216
Splanchnic
arterioportal fistula 607
circulation, anatomy of 166
Spleen 224f, 412f, 507
absence of 552f
accessory 549
infectious diseases of 554
length in
adolescents 548t
children 548t
ligaments of 505, 508
lower part of 613
parenchyma 555f
Splenectomy 578, 579f
Splenic arteriogram 613
Splenic artery 9, 18f, 166, 568f
aneurysm 566, 568f
distal 184f, 192f, 567f
embolization 493
lower branch of 613
pseudoaneurysm 192f, 415f, 425f
Splenic embolization, partial 611, 613
Splenic flexure 543f
Splenic hilum 342f
Splenic infarction 544
Splenic infarcts 556
Splenic injuries 493
Splenic masses, multiple small 552
Splenic neoplasms 558
Splenic parenchyma 494f, 544, 569f
hematoma 492f
Splenic rupture 557
Splenic size 548
Splenic vein 237, 407, 593, 605f
patency of 595
Splenoportal axis
anatomy of 594f
dilated 597
Splenoportal thrombosis 173f
Splenorenal 597
ligament 507, 508
shunt 603f
Spontaneous bacterial peritonitis 226, 593
Spontaneous shunts 601t, 603
Sporadic burkitt lymphoma 538
Squamous cell carcinoma 39, 43, 44f, 51t
Stainless steel coils 617f
Static elastography 6
Steady state fast field echo 16
Stealth lesion 257
Stenosis 23
Steroid intake 215
Stomach 412f, 507
antrum of 64
benign tumors of 57
carcinoma of 59, 66f
fundal region of 618f
fundus of 33
greater curvature of 543f
ligaments of 505, 507
malignant tumors of 57, 59
surgeries of 583
wall, muscularis of 74
Stone retention 588
Stool, frank blood in 166
Stromal tumors 83
Subcutaneous emphysema 575
Subcutaneous fat, edema of 576f
Subhepatic
drain 584
location 202f
region 533f
space 510
Subphrenic space 509
Succinate dehydrogenase 97
Sulfur hexafluoride 240
Superparamagnetic iron oxide 254
Suppurative appendicitis 202f
Supramesocolic space 509
Surgery, abdominal 523f
Suture anchoring set 623
Swallowing, physiology of 20
Synchronous cancers 124f
Syndromes, number of 75
Syphilis 226
T
Tachycardia 583
Target sign 275
T-cell lymphoma 103, 111
jejunum 107
Telangiectasia 367
Tetracycline 398
Thermal ablation 308
Thiazides 398
Thoracic esophagus 40f, 628f
distal 41f
Thoracoabdominal aorta 480
Thoracoscopic assisted esophagectomy 583
Thyroid gland, enlarged 53
Tissue plasminogen activator 186
Total parenteral nutrition 215
Toxic megacolon 481
Toxic-metabolic 419
Toxins 215
Trans-abdominal sonography 421
Transarterial
chemoembolization 290, 306, 310, 316, 326
radioembolization 326
radionuclide therapy 313
Transcatheter
arterial embolization 316
chemoembolization 310f
Transfusional siderosis 223
Transhepatic shunt 600, 603
Transient fluid collections 589
Trauma 511, 557
abdominal 485
life support, advanced 485
penetrating abdominal 502
Triangular ligaments 508
Tropical chronic pancreatitis 430
Trypsin 398
Tube dislodgement 624
Tubercular cholangitis 224, 275
Tubercular peritonitis 517f
Tubercular pyelophlebitis 224
Tuberculosis 37, 38f, 143, 145, 224, 446, 559f
abdominal 145, 527f, 579
disseminated 558f
Tuberculous
lymphadenitis 523
peritonitis 514
Tumor 48, 194, 325
benign 77, 84, 212
malignant 89, 223
node metastasis 450
nodules 73, 533
of appendix 211
of colon, secondary 137
of duodenum 57
of pancreas involving duodenum 79
of peritoneum, primary 526t
of stomach 57
primary 120, 625
secondary 625
size 42
spread of 62
staging manual 60
thrombus in left portal vein 608f
treatment of malignant 306
types of 83
vascularity 321
Turcot's syndrome 88
Tyrosine kinase inhibitor 42, 101
U
Ulcer, deep 159f
Ulceration 42, 61
central 79
Ulcerative colitis 162, 162f, 223, 580
Ulcerative form 68
Ultrasound elastography 280, 422, 435
Umbilical ligaments 509
Uncinate process of pancreas 441f
Unidimensional transient elastography 6
Unilocular cyst 456f
Unresectable pancreatic cancer 448f
Unresectable tumors 447
Urinary
bladder 532
colic, acute 482
tract 498
injuries 498
V
Vallecula 24f
malignant right 30
Variceal bleeding 226
Variceal rupture secondary 317f
Varices 601
Vascular causes 480
Vascular injury 490, 493, 588
Vascular ring 53
Vascular thrombosis 586
Vasculitis with mesenteric angina 176f
Vasoactive intestinal peptide 465
Vena cava
extension, inferior 286f
inferior 326, 336, 593, 611
interior 5f
Veno-occlusive disease 337
Venous
ischemia 170f, 172
mesenteric ischemia 169
occlusive ischemia 173t
thrombosis 411
Ventral mesentery 505
Vertebrolumbar azygous pathways 341
Vesicouterine 511
Videofluoroscopic swallowing study 22, 25
Villous adenoma 79
Viral
esophagitis 37
hepatitis 219
Visceral abscesses, detection of 476
Visceral peritoneum 505
Volume rendered technique 9f
von-Gierke's disease 259
von-Meyenberg's complexes 250
W
Walled-off necrosis 401, 408
Wandering spleen 550
Water attenuation, multiseptated mass of 263f
Water-soluble contrast 4
Watery diarrhea 465
WDHA syndrome 465
Whipples procedure 588
Whirl sign 477f
White blood cell 566
blood 68
Wilson's disease 215, 224, 225f
Wound
complications 580
contamination 624
infection 581f
X
Xanthogranulomatous cholecystitis 361, 363f
Z
Zenker's diverticulum 23
×
Chapter Notes

Save Clear


Imaging Techniques

Imaging Techniques for AbdomenCHAPTER 1

Smriti Hari,
Smita Manchanda
 
INTRODUCTION
The imaging techniques for evaluation of abdomen have evolved dramatically over the past few decades. Conventional radiographs and barium studies now have a limited role with the cross-sectional imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) being the mainstay of diagnosis. Ultrasound remains the first line investigation for suspected hepatobiliary and pancreatic pathologies. The recent advent of ultrasound contrast agents and elastography techniques has improved the diagnostic yield of ultrasound. The routine contrast-enhanced CT and MRI have been modified in the form of multiphase acquisition and enterography/colonography for an optimal delineation of hepatic/pancreatic and bowel pathologies respectively. There has been a significant advancement in the nuclear imaging studies with the advent of hybrid scanners like positron emission tomography (PET)-CT and PET-MRI that are capable of providing both anatomical and functional information.
 
CONVENTIONAL TECHNIQUES
Conventional radiographs of the abdomen are now limited to the emergency setting for the evaluation of suspected perforation and intestinal obstruction.
 
BARIUM STUDIES
Endoscopy is the investigation of choice for most esophageal pathologies with a complimentary role for barium studies. However, fluoroscopic barium studies (Fig. 1.1) are essential in the evaluation of motility disorders.
The stomach and duodenum are also best evaluated by endoscopy in cases of dyspepsia and abdominal pain. However, barium studies (Fig. 1.2) are required for assessing functional abnormalities like reflux and delayed emptying; submucosal masses and infiltrative processes. The barium/gastrografin oral contrast study is also the technique of choice for evaluation of early postoperative complications following gastric surgery.
For radiological evaluation of small bowel, both barium follow through (Fig. 1.3) and enteroclysis (Fig. 1.4), are superior to CT/MRI examination in terms of demonstration of fine mucosal detail. The conventional enteroclysis has the advantages of shorter examination time, better distension of small bowel and better visualization of pathology but requires more radiologist time, greater technical skill, gives more radiation dose to patient and operator and is relatively uncomfortable for the patient.
zoom view
Fig. 1.1: The lower thoracic esophagus and gastroesophageal junction well seen in the distended state in a normal barium swallow
zoom view
Fig. 1.2: Supine radiograph of double contrast barium swallow showing well-distended stomach and normal mucosal pattern
zoom view
Fig. 1.3: Barium followthrough examination showing well-distended jejunal loops with normal villous pattern
zoom view
Fig. 1.4: Conventional small bowel enteroclysis showing normal distended jejunal and ileal loops in double contrast
zoom view
Fig. 1.5: Double contrast barium enema. Supine radiograph showing normal mucosal outline of the cecum, ascending colon, part of transverse colon and descending colon. The hepatic flexure and rectosigmoid colon are in a dependent position and hence seen in a barium-filled state
Small bowel follow through study is easy to perform, allows estimation of transit time and is more comfortable to the patient. However, complete and adequate distension of small bowel cannot be achieved in followthrough study.1,2
Colonoscopy is the investigation of choice for evaluation of colorectal diseases. However, barium enema (Fig. 1.5) is useful for delineating colonic caliber and configuration.3 Also barium contrast enema is preferred in patients with question of large bowel obstruction, need for localization of colonic disease preoperatively or to assess the status of colon anastomosis.
Prior to undertaking any barium procedure, appropriate medical history along with results of previous investigations (including imaging and endoscopic procedures) should be obtained. Table 1.1 highlights the indications, contraindications, brief technique along with special modifications of the commonly performed barium procedures.47
 
ULTRASONOGRAPHY EVALUATION OF THE LIVER
Sonography is used as the initial imaging modality for suspected liver pathology.8 It plays a vital role in the evaluation of focal liver lesions, screening for liver metastases in a patient with known malignancy, screening for hepatocellular carcinoma in the setting of hepatitis/cirrhosis, portal hypertension, surgical obstructive jaundice, hepatic veno-occlusive disease and preoperative work-up and postoperative follow-up of liver transplant patients.3
Table 1.1   Commonly performed barium procedures
Procedure
Indications
Contraindications
Patient preparation
Examination technique
Modifications
Barium swallow
  • Dysphagia
  • Odynophagia
  • Reflux disease
  • Atypical chest pain
  • Recent esophageal surgery
  • Recent gastric surgery
  • Recent trauma
  • Uncooperative patient
  • Nil orally for a minimum of 2 hours prior to the procedure
  • No smoking
  • Low density (60–95% weight per volume [weight/volume]) barium suspension is used
  • Esophagus anatomy and motility is evaluated under fluoroscopy
  • Spot images taken to document normal (barium-filled and mucosal relief views) and abnormal findings
  • Gastroesophageal junction is documented-along with evaluation for reflux
  • Double contrast: Performed using a high-density (210–250% weight/volume) barium suspension along with an effervescent agent
Water-soluble contrast agent: In cases, where leak or perforation is suspected
Iso-osmolar or low-osmolar contrast or dilute barium: In cases, where aspiration or esophageal-tracheal or bronchial fistula is suspected
Barium meal upper GI
  • Suspected reflux
  • Epigastric pain/discomfort
  • Dyspepsia
  • Upper GI bleeding
  • Anemia
  • Weight loss
  • Recent esophageal surgery
  • Recent gastric surgery
  • Recent trauma
  • Uncooperative patient
  • Nil orally after midnight, a day prior
  • No smoking
  • Fluoroscopic evaluation of esophagus, stomach and duodenum
  • Double contrast: Performed using a high-density (210–250% weight/volume) barium suspension along with an effervescent agent
  • Spot images to document normal and abnormal findings
  • Barium-filled and mucosal relief views of esophagus, stomach and duodenum
  • Overhead images for full anatomical delineation of stomach
Water-soluble contrast agent: In cases, where leak or perforation is suspected
Barium follow-through
  • Suspected small bowel obstruction
  • Unexplained GI bleeding
  • Malabsorption
  • Suspected enteric fistula
  • Abdominal pain
  • Diarrhea
Uncooperative patient
Nil orally after midnight prior to the procedure
  • 600 mL of 50% weight/volume barium suspension
  • Oral administration over one hour
  • Fluoroscopic evaluation after 30 minutes and regular overhead radiographs in prone position
  • Spot compression views of any focal abnormality
  • Compression of accessible loops
  • Ileocecal junction demonstration
  • Peroral pneumocolon, if required for better delineation of distensibility of cecum and ileocecal junction
Water-soluble contrast agent: Preferred, if there is suspicion of bowel leak or obstruction4
Enteroclysis
  • Recurrent small bowel obstructions
  • Unexplained weight loss or gastrointestinal (GI) bleeding
  • Anemia
  • Malabsorption
  • Inability to pass catheter
  • Patient intolerance for catheter
  • Nil orally after midnight before the procedure
  • Laxative may be given on the day prior to the examination
  • Enteroclysis catheter placed under fluoroscopic guidance and nasal anesthetic spray
  • Tip-positioned several centimeters beyond the duodenojejunal flexure
  • Single-contrast examination
  • Medium-density barium suspension given via the tube to maintain adequate small bowel distension
  • Double-contrast examination
  • High-density barium suspension followed by 0.5% solution of hydroxypropyl methylcellulose, volumen or room air
  • Administered under fluoroscopic guidance, double-contrast mucosal coating and optimal distention of small bowel
  • Infusion rate controlled to avoid excessive peristalsis
  • Avoid reflux of large amounts of this fluid into stomach
  • Technique: External compression, rotation and palpation
  • Separate overlapping bowel loops
  • Spot compression views
  • Overhead large-format
  • Images of completely distended small bowel
Barium enema
  • Abdominal pain
  • Diarrhea/Constipation/Change in bowel habits
  • Gastrointestinal bleeding
  • Anemia
  • Abdominal masses
  • Weight loss
  • Fever or sepsis
  • History of previous colon polyp or neoplasm
  • Familial inheritance pattern diseases involving the colon
  • Unexplained pneumoperitoneum
  • Toxic colon
  • Uncooperative patient
Relative: Rigid colonoscopy and biopsy
  • Colon preparation to remove fecal matter and excess fluid
  • Dietary restriction
  • Hydration
  • Laxatives
  • Cleansing enemas
  • Single-contrast enema
  • Low-density (15–25% weight/volume) barium suspension or water-soluble contrast
  • Spot compression views
  • Frontal views of entire filled colon
  • Lateral view of rectum
  • Angled-beam view of sigmoid colon
  • Postevacuation images
  • Double-contrast barium enema
  • Commercially available high-density (80% weight/volume or greater) barium suspension
  • Barium suspension and air introduced under fluoroscopic control
  • All segments of colon documented in double contrast
  • Overhead supine and prone radiographs of entire colon
  • Lateral view of rectum
Water-soluble contrast:
  • Immediate postoperative period
  • Suspected perforation
  • Bowel preparation not possible
  • Blind-ending colonic segments (e.g. Hartmann pouch)
  • May be therapeutic in cases of meconium ileus equivalent (cystic fibrosis)
Abbreviation: GI, gastrointestinal
5Sonography effectively differentiates a solid from a cystic lesion and provides significant information regarding the internal architecture of indeterminate lesions.
The addition of color Doppler flow imaging further helps in characterizing mass lesions and assessing patency of vessels.9 Doppler is particularly helpful in liver transplants, Budd-Chiari syndrome and cirrhosis.
 
Technique
The liver is scanned in the supine or left decubitus position with a 3.5–5 MHz convex transducer in the transverse, sagittal and oblique planes, from a subcostal approach. The sub-costal approach may not suffice in all patients and intercostal scanning may have to be done with a small footprint transducer.9 This is especially true in shrunken cirrhotic livers. An attempt is made to delineate the venous landmarks so that all the liver segments can be identified and scanned sequentially.
 
Sonographic Anatomy
Liver parenchyma is imaged as fine homogeneous mid-level echoes interrupted only by fissures and vessels. The liver echogenicity is usually greater but may be equal to renal echogenicity. Hepatic veins (Fig. 1.6) are well-defined tubular structures without significant marginal echoes, whereas portal veins have echogenic walls due to fibrous and fatty tissue (Fig. 1.7). Bile ducts run parallel to portal vein branches, but their location in relation to veins is variable, and the axiom that ducts are always anterior to portal vein branches is not correct. The state of art electronically focused ultrasound equipment demonstrates normal intrahepatic biliary radicles quite well and a bile duct must be at least 40% of the size of its neighboring portal vein branch for it to be considered dilated. Therefore, the mere visualization of parallel channels in the liver parenchyma does not indicate biliary dilatation.9
zoom view
Fig. 1.6: Transverse US scan showing the three hepatic veins (arrow) joining the interior vena cava (IVC)
The gallbladder is located in the interlobar fissure and is well evaluated by ultrasound. The wall of the gallbladder should not be thicker than 3 mm in the fasting state. The common duct lies anterior to the portal vein at the porta hepatis and should be measured at the place where the hepatic artery crosses perpendicularly between them. This level has been used because of the consistent acoustic window provided by the surrounding liver, which ensures reproducibility of the measurement. The common duct should not be wider than 6 mm at this point.
On Doppler examination, the normal hepatic vein trace reflects the transmitted right heart pressure changes leading to flow reversal during the right atrial contraction (Fig. 1.8). The portal vein trace is continuously antegrade with a mean peak velocity of 15–22 cm/s. The portal venous flow shows slight undulation related to the cardiac cycle and respiration (Fig. 1.9).
 
Intraoperative Ultrasonography
Intraoperative and laparoscopic ultrasonography (US) are very useful techniques that have had major impact on patient management. A 5–7 MHz T-shaped linear array probe is used for intraoperative scanning. The probe can be sterilized using ethylene oxide gas sterilization. The probe is applied directly to the liver surface and no gel or acoustic coupling agent is necessary.
zoom view
Fig. 1.7: Ultrasonography scan showing the bifurcation of main portal vein (MPV) into the right (RPV) and left portal veins (LPV)
6
zoom view
Fig. 1.8: Color Doppler flow imaging of hepatic vein showing normal triphasic flow pattern with a short phase of reversed flow
The liver is scanned from the dome to the caudal edge and from left to right in a sequential manner. Color Doppler can be coupled with the gray scale scan and is very useful to identify vascular landmarks and assess their patency.
Intraoperative ultrasonography (IOUS) provides useful real time information to the surgeon and can alter the surgical approach. Current applications for IOUS include tumor staging, metastases evaluation, tumor ablation processes, evaluation of patency of vessels, intrahepatic biliary disease, and in liver transplantation.9
 
Endosonography
The development of endoscopic US (EUS) has rendered the gastrointestinal tract amenable to high resolution US examination and histopathologic sampling when required in the same session. Higher frequency probes (6–10 MHz) are used during EUS and the echoendoscopes have biopsy channels for performing fine-needle aspiration (FNA).10 It is useful for assessing the depth of tumor invasion and sampling of smaller lesions and adjacent lymph nodes. It is being used to stage esophageal and stomach malignancies in many centers.
Similarly, transrectal ultrasonography can be used for staging of colorectal carcinomas. Anal endosonography is useful in patients with injury to the external anal sphincter and presenting with fecal incontinence.
Endoscopic US is also used for the characterization of cystic lesions of the pancreas by identifying the ultrasound morphology and performing FNA with cyst aspiration.10
 
USG Elastography
Elastography is a recent development, which gives a measure of tissue stiffness.11,12 Depending on the deforming force applied and the method used to study the resultant deformation, it can be classified as:
  • Static elastography
  • Impulse elastography
    • Unidimensional transient elastography (Fibroscan)
    • Acoustic radiation force impulse (ARFI) imaging mode elastography
    • Shear wave elastography.
zoom view
Fig. 1.9: Color Doppler flow imaging of portal vein showing continuous antegrade flow with minimal phasicity
Acoustic radiation force impulse (ARFI) elastography gives a quantitative measure of the shear wave speed (in m/s) induced by acoustic radiation through an external vibrator. The measurement area is a 1 × 0.5 cm rectangle placed on the B-mode ultrasound image. These measurements are taken in the right lobe of liver through the intercostal space. Its main use is in the assessment of liver fibrosis and hepatic masses. However, this technique is not real time, does not give standard deviation and the size of the measurement area cannot be changed.11
Shear wave elastography measures the speed of shear waves that are produced in the tissue perpendicular to the direction of displacement when a focused ultrasound beam provides an acoustic ‘push’. The acquisition is real time with simultaneous display of the B-mode image and the corresponding shear wave elastography image (two- dimensional box with elastography color map). The speed of shear waves is used to calculate the elasticity in kilopascals (kPa and real time measurements can be made by placing the Q box over the region of interest (Fig. 1.10). The system generates the maximum, minimum and mean values along with the standard deviation. The size and position of the Q-box can be altered and in addition, retrospective measurements can be made with this system.7
 
USG Contrast Agents
Contrast-enhanced ultrasound (CEUS) uses microbubble-based contrast agents to improve the echogenicity of blood. It has major clinical applications in echocardiography, hepatology and vessel evaluation. It can be easily peformed after baseline ultrasound in the same sitting and provides functional vascular information without the use of ionic radiation.
zoom view
Fig. 1.10: Shear wave elastography of the liver seen as dual display. The color in the box corresponds to the velocity of the shear waves. The velocity is measured in kilopascals and is displayed in the vertical bar on the right
The microbubbles have an average diameter of 1–4 µm and they oscillate at ultrasound frequencies of 1–15 MHz. These nonlinear oscillations generate echoes which are detected by the imaging system. With the availability of phase modulation and amplitude modulation techniques, the sensitivity of ultrasound equipment for microbubble detection has consistenly improved in the last decade.13
Examples of commonly used contrast agents include SonoVue (sulfur hexafluoride microbubble) and Levovist (microcrystalline suspension of galactose and palmitic acid). The contrast agent is available in the lyophilized powder form, which is to be mixed with 5 mL of 0.9% normal saline and injected as a rapid IV bolus followed by 5–10 mL of saline flush. USG scanning is started immediately and takes approximately 4–5 minutes. For the evaluation of liver lesions, real time imaging is performed through the arterial, portal venous and parenchymal phases (Figs 1.11A and B). Contrast is seen to pass through the hepatic artery and its branches with liver echogenecity increasing from the arterial to the portal phase. Lesion echogenecity is compared to the parenchyma at the same depth and their enhancement pattern is compared with that of the blood pool.13,14
 
USG Image Fusion and Navigation
The higher end ultrasound machines provide integrated image fusion and instrument navigation capabilities. The image navigation system provides real time guidance for soft tissue biopsy and ablation procedures in ultrasound combining the cross-sectional data available.
zoom view
Figs 1.11A and B: Small HCC in a 30-year-old man with chronic liver disease: (A) Arterial phase US image obtained 20 seconds after contrast material injection demonstrates diffuse homogeneous enhancement of the nodule (arrow); (B) Delayed phase US image obtained 192 seconds after injection shows washout (arrows)
8Image fusion techniques makes it possible to target those lesions which are not well visualized on USG but are seen on another modality like CT or MRI. The CT/MRI images of the patient are added onto the ultrasound fusion system. The two-dimensional cross-sectional images are then transformed into dynamic, fused imaging maps that combine CT or MR imaging with live ultrasound.
 
CT EXAMINATION OF THE ABDOMEN AND PELVIS
For complete CT evaluation of abdomen and pelvis, images are acquired in the axial plane from the dome of diaphragm to below the ischial tuberosities in suspended respiration. The slice thickness is 5 mm or less. CT examination is optimized for each patient according to the relevant history and clinical indication. This includes determining the need for non-contrast scan and planning of the study as a single phase or multiphase study.15
Enteric contrast agent is used for better delineation of bowel loops and can be administered orally, via nasogastric tube, per rectally or in varying combinations. Positive contrast agents include dilute barium (1–2%) and water-soluble iodinated contrast material (2–3%). These help to differentiate intraluminal from extraluminal pathology and detect suspected leaks. However, bowel wall enhancement characteristics are difficult to interpret when positive contrast agents have been used. Similarly, they also interfere with the 3D reformatted angiographic images and should not be used in cases of suspected GI bleed.15,16
Neutral contrast material is more useful when bowel wall characteristics need to be evaluated and in vascular studies. These include water and agents with water density like mannitol, lactulose and methylcellulose. However, the evaluation of abscesses and hypodense collections becomes more challenging with use of neutral contrast agents.
Negative contrast agents like air and carbon dioxide are used routinely in CT colonography for optimal colonic distension.
When single-phase acquisition is planned, intravenous nonionic iodinated contrast (100 mL of 350 mg I/mL) is administered and images are acquired after 50–70 seconds. When evaluating CT abdomen, care should be taken to use different widow width and window level settings for viewing the visceral organs, the intra-abdominal fat, bony anatomy and lung bases as well. Multiphase acquisition is planned according to the area of interest as described below.15
 
CT Evaluation of Hepatic Pathology
Multiphase CT scanning should be performed for the evaluation of liver pathology.
 
Multidetector CT Evaluation
Typically a triple phase CT is performed in case of suspected liver lesion.
Non-contrast scan has a limited role, and is of use predominantly in patients treated with TACE or other ablative therapies. It can help to assess post-contrast enhancement in patients with siderotic nodules of increased attenuation. However, in order to keep the radiation dose low, most studies now do not recommend acquisition of the pre-contrast scan.17,18
Intravenous contrast is administered in a dose of 1.5–2 mL per kg body weight. The total iodine dose should be 525 mg iodine per kg or more; assuming iodine concentration of contrast to be 350 mg iodine per milliliter. Contrast should be administered at a flow rate of 3–4 mL/s using dual head mechanical injector and followed by saline flush. Most scanners now provide bolus-tracking software and passage of contrast through the descending aorta should be monitored to start the image acquisition.19,20
The images are acquired in the arterial, portal venous and delayed phases. The early arterial phase (about 10 seconds after the injection) is characterized by enhancement of the hepatic artery but not the portal vein. This phase is reserved for patients in whom CT angiography is required, such as potential transplant recipients, candidates for hepatic resection or cryoablation, or candidates for chemo- embolization.21 CT angiography images can be created through three-dimensional reconstructions of the thin slice, isotropic images obtained in the early arterial phase. Water is preferred as the oral contrast agent for multiplanar CT angiography to allow optimal reconstructions from the 3D data sets. Maximum intensity projection, surface-shaded display, and volume-rendered techniques are used in the post-processing of CT angiography to depict vascular anatomy (Figs 1.12A and B).
The late arterial phase, which is acquired 20 seconds after contrast injection, is characterized by enhancement of hepatic artery, its branches and the portal vein.22 This phase is critical for picking up hypervascular tumors. A combined CT angiogram/CT portogram can be obtained from the late arterial imaging phase and is used for delineation of the extrahepatic portal venous system in transplant cases and patients with pancreaticobiliary malignancy.21 Venous compression, venous stenosis or thrombosis, and portal systemic venous collateral vessels can be displayed.
This is followed by the portal venous phase acquisition at 60–80 seconds after the start of injection of contrast. In this phase, there is peak parenchymal enhancement with optimal opacification of both the portal veins and the hepatic veins.19,23
The delayed phase is acquired to study the washout characteristics of liver lesions, capsular enhancement and to observe the delayed contrast enhancement of certain tumors like cholangiocarcinomas.9
zoom view
Figs 1.12A and B: Coronal maximum intensity projection [MIP] (A) and volume rendered technique [VRT] (B) reconstructed from the axial MDCT images obtained during early arterial phase of contrast enhancement demonstrates abdominal aorta and its branches.Abbreviations: CA, celiac axis; SMA, superior mesenteric artery; SA, splenic artery; GDA, gastroduodenal artery; RHA, right hepatic artery; LHA, left hepatic artery; RRA, right renal artery; LRA, left renal artery
Table 1.2   Multidetector CT protocol (Hepatic evaluation)
Intravenous Contrast:
Iodinated contrast medium: Iodine concentration 350 mg/mL
  • Volume: 1.5–2 mL/kg
  • Flow rate: 3–4 mL/s
  • Bolus tracking software
  • Mechanical injector with saline flush
Oral contrast: 600 mL tap water
Image acquisition:
  • Non-contrast phase
    • Before the injection of contrast material
    • In patients treated with ablative therapies
  • Late arterial phase
    • 20 seconds after start of injection
  • Portal venous phase
    • 60–80 seconds after start of injection
  • Delayed phase
    • >120 seconds after start of injection (3–5 min)
This is acquired at 3–5 minutes post-contrast injection.19
The protocol has been summarized in Table 1.2.19,23
 
Dual Energy CT Evaluation
Triple-phase CT on a dual energy CT scanner is performed similarly as described above for the multidetector CT. The main advantage is generation of virtual unenhanced images without adding to the radiation dose (Figs 1.13A to D). These help to detect the presence of calcification and fat within lesions. Few studies have reported that it is feasible to quantity iron deposition in the liver, with dual energy CT.24
 
VOLUME ESTIMATION
Volume estimation of the liver (Fig. 1.14) helps in accurate planning of hepatic resection by delineating the exact 3D anatomy of the liver.21 Estimation of liver volume using three- dimensional techniques, when combined with clinical and laboratory evaluation of liver function, can aid in predicting postoperative liver failure in patients undergoing resection, assists in embolization procedures, and planning of staged hepatic resection for bilobar disease.25
 
MULTIDETECTOR COMPUTED TOMOGRAPHY EVALUATION OF PANCREATIC PATHOLOGY
For the evaluation of the pancreas, multiphase acquisition (Figs 1.15A and B) is recommended.26
The precontrast images are followed by the arterial phase at 17–25 seconds after the start of contrast injection. This phase is recommended wherever optimal delineation of the arterial supply is required.
The peak parenchymal enhancement of the pancreas is seen at 35–50 seconds after the start of contrast injection. This pancreatic phase is best for peak tumor-parenchymal attenuation difference. Curved multiplanar reformat (MPR) can be obtained along the pancreatic duct for showing relationship of the duct with the tumor (Table 1.3).
The portal venous phase is acquired 55–70 seconds after the start of contrast injection and is ideal for depiction of venous involvement and liver metastases.26,27 Minimum intensity projection (MinIP) images are used to delineate the anatomy of the pancreatic and biliary tree, which are seen as low-density structures.10
zoom view
Figs 1.13A to D: Multiphase CT acquisition for liver performed on a dual energy scanner. Virtual non-contrast (A), arterial (B), portal venous (C) and delayed (D) phase images reveal widening of the fissures in this known case of chronic liver disease. No focal lesion was detected
 
BOWEL EVALUATION
 
CT Enteroclysis
Computed tomography (CT) enteroclysis involves the insertion of a nasojejunal tube under fluoroscopic guidance. The catheter tip is placed in the proximal jejunum and 1.5 L saline infused at 100 mL/min followed by on table infusion of 1.5 L saline with 100–120 mL intravenous contrast administration and single portal venous phase acquisition.28 It has been replaced by CT enterography at most institutions.
 
CT Enterography
This is the preferred examination technique for the evaluation of small bowel pathology and is replacing traditional barium fluoroscopic studies, especially in cases of Crohn's disease.29
Neutral oral contrast agents are administered for optimal distension of small bowel. Bowel is prepared by prior fasting for 8 hours and intake of 50–100 mL of laxative diet solution (Polyethylene glycol lavage) one day prior to the study.16 The neutral oral contrast agents used include water, mannitol, lactulose, methylcellulose, polyethylene glycol and 0.1% barium suspension. The CT attenuation of these agents is 0–30 HU and provides optimal contrast between bowel wall and lumen.29
The oral contrast should be consumed over 30–60 minutes. The protocol varies with institutions and a suggested protocol is given in Table 1.4.16 Intravenous contrast is given (100–120 mL @ 3–4 mL/sec) and single-phase images are acquired between 50–70 seconds (either enteric or portal 11venous phase). However, in cases of obscure GI bleeding, both the arterial and portal venous phases must be acquired. Multiplanar reconstructions in the coronal plane (Fig. 1.16) better depict the anatomical relation of bowel loops and maximum intensity projection (MIP) images provide angiographic images for suspected GI bleed.29
 
CT Colonography
CT colonography (Table 1.5)16 is a minimally invasive procedure for evaluation of the large bowel. It can be used as a screening, surveillance or diagnostic modality depending on the patient profile. Colonic preparation is essential and consists of low fiber diet (for 1–3 days), hydration and 50–100 mL of laxative diet solution (Polyethylene glycol lavage), one day prior to the study. Fecal tagging is usually performed with oral administration of water-soluble iodinated contrast or dilute barium. This is done to incorporate positive contrast into residual fecal material and increase its CT density. The increased density helps to distinguish fecal material from polyps or malignancy.30
The patient should be asked to evacuate prior to the study. Soft and flexible rectal catheter is inserted and the colon is insufflated with carbon dioxide (mechanical) or room air (manual).
zoom view
Fig. 1.14: CT volumetry in a patient planned for partial liver resection. Segments II and III are manually mapped out on contiguous axial slices and the volume is calculated using volumetric software
Table 1.3   MDCT pancreatic protocol (Image acquisition)
  • Arterial phase:
    • 17–25 seconds after start of injection
    • For angiography images and arterial supply delineation
  • Pancreatic phase:
    • 35–50 seconds after start of injection
    • Peak tumor-parenchymal attenuation difference
  • Portal venous phase:
    • 55–70 seconds after start of injection
    • Venous involvement and metastases
Table 1.4   CT enterography protocol
  • Nil orally
  • Intestine cleansing: Polyethylene glycol lavage
  • Oral contrast:
    • 300 mL 20% w/v mannitol mixed with 1.5 L water
    • 500 mL mixture given orally every 15 minutes
    • Remaining solution: On table oral administration
  • Scan performed at 50 minutes
  • Intravenous contrast injection:
    • 100–120 mL @ 3–4 mL/sec
    • Single phase/Multiphase acquisition
zoom view
Figs 1.15A and B: Multiphase CT acquisition for pancreas performed for suspicious lesion on USG. Pancreatic phase (A) is acquired at 35 seconds and portal venous phase (B) at 65 seconds after the injection of contrast medium. No focal lesion was detected
12
zoom view
Fig. 1.16: CT enterography (coronal reformatted image) showing normal distension of the small bowel loops with no abnormal enhancement
Table 1.5   CT colonography protocol
  • Patient preparation
    • Low fiber diet
    • Adequate hydration
    • Intestinal cleansing: Polyethylene glycol lavage
  • Fecal tagging: Oral administration of iodinated contrast or dilute barium
  • Evacuation prior to the study
  • Colonic distension: Carbon dioxide/Room air
  • Scanning:
    • Pre-contrast images; prone position
    • 100–120 mL intravenous contrast administration
    • Portal venous phase acquisition; supine position
CT scout film should be taken to check the adequacy of colonic distension. Low dose pre-contrast scan is acquired in the prone position, followed by intravenous contrast administration. Images are then acquired at 50–70 sec in the portal venous phase in the supine position. Optimal colonic distension is indicated by pencil thin colonic wall with thin haustral folds. Axial and coronal reconstructed images can be analyzed using CAD software, wherever available.16,30
 
MAGNETIC RESONANCE IMAGING
Magnetic resonance (MR) imaging is an excellent imaging modality because of its high contrast resolution, multiplanar capability, sensitivity to blood flow and lack of ionizing radiation. Technical advances in MR hardware and software have allowed the introduction of faster pulse sequences without the motion artifacts that previously posed limitations to abdominal MR imaging. The use of parallel imaging techniques with multi-channel phased array coils has significantly reduced the scan time. MRI of the abdomen (Table 1.6) is now an important modality for imaging the abdomen encompassing a variety of sequences, which are continuously being improvised.31
Higher field strengths are preferred (1.5 T or 3T) for abdomen evaluation. The advantage of 3T imaging systems is increased signal-to-noise ratio, better delineation of post- contrast enhancement and reduced time for chemical shift sequences (echo times of in and opposed phase sequences is less compared with 1.5 T). At the same time, in comparison to 1.5T, 3T scanners have increased specific absorption rate (SAR) and suffer from greater magnetic field inhomogeneity making images more prone to susceptibility and chemical shift artifacts.32,33
Phased array surface coil is used for abdomen evaluation. T1 and T2 weighted imaging is performed using breath-hold or respiratory triggered sequences. The acquisition is usually multiplanar with slice thickness of 5–8 mm and interslice gap not more than 3 mm. Either spin-echo (TSE or FSE) or gradient echo sequences can be used for T1-weighted imaging, with at least one in and out-of-phase gradient T1 sequence. T2-weighted images include either spin-echo sequences (TSE or FSE) or hybrid gradient and spin-echo (GRASE) sequences. Fat suppression is required during T2 weighted imaging, and can be achieved by chemical selective fat saturation, short tau inversion recovery (STIR), or spectral presaturation inversion recovery (SPIR). 3D sequences (both T1 and T2) are also available and provide higher SNR with better fat suppression. Intravenous contrast (gadolinium chelates) is used depending on the study protocol. Post-contrast administration, 2D or 3D T1-weighted sequences with fat suppression are acquired.31
Heavily T2-weighted magnetic resonance cholangio-pancreatography (MRCP) sequences are used for evaluation of the biliary and pancreatic ductal system. The sequences used are breath-hold rapid acquisition relaxation enhancement (RARE) or half-Fourier single-shot echo train spin-echo sequence as a thick slab acquisition (Fig. 1.17) in multiple projections or as multiple thin (less than 5 mm) slices in coronal or axial plane.13
Table 1.6   MRI abdomen protocol
  • Fasting for 6 hours
  • Pelvic phased array surface coil
  • IV buscopan (1 mL~20 mg)
  • Sequences
    • T2WI: Fat suppressed; spin echo/ hybrid sequence (axial, coronal)
    • Steady state fast field echo sequence: Axial
    • T1 in and opposed phase (Axial)
    • DWI (b value 0, 400, 800)
    • T2 (Multiecho)
    • MRCP:
      • Breath-hold rapid acquisition relaxation enhancement (RARE) or half-Fourier single-shot echo train spin-echo sequence (Thick slab acquisition)
      • 3D respiratory-triggered T2- weighted FSE technique
  • Post contrast (Multiphase acquisition)
    • 2D or 3D T1 weighted sequences with fat suppression
  • Pancreatic protocol
    • Arterial phase: 20 seconds after start of injection
    • Portal Venous phase: 45–65 seconds after start of injection
    • Equilibrium phase: 3–5 min after start of injection
  • Hepatic Protocol
    • Late arterial phase: 20 seconds after start of injection
    • Portal venous phase: 60–80 seconds after start of injection
    • Delayed phase: >120 seconds after start of injection (3–5 min)
    • Hepatobiliary phase: Gadobenate dimeglumine (MultiHance): one hour postcontrast injection
    • Gadoxetate (Eovist): 20 minutes postcontrast injection
zoom view
Fig. 1.17: Choledocholithiasis. Coronal thick slab projectional MRCP reveals multiple calculi in the common bile duct and right hepatic duct
3D respiratory-triggered T2- weighted FSE techniques with maximum intensity projection (MIP) reconstruction (Fig. 1.18) can also be used.31
Diffusion-weighted imaging for abdomen uses single-shot echo-planar sequences, breath-held or respiratory triggered. At least two b-values are used (b = 0 to 50 s/mm2 and b = 500 to 1,000 s/mm2) and ADC maps are generated for proper interpretation. DWI has short acquisition time and is now a part of the routine protocol. In patients with contraindications to MR contrast this sequence is particularly advantageous.16,31
zoom view
Fig. 1.18: MRCP (MIP) image showing normal intrahepatic biliary radicles, common bile duct and pancreatic duct in a case of carcinoma gallbladder
 
MRI of the Liver
MRI has evolved from a problem solving technique to first line investigative modality for liver lesions.14
Pelvic phased array surface coil is used with field of view including the entire liver. Acquisition is predominantly in the axial plane with additional coronal plane imaging to better depict the vascular anatomy and the hepatic dome.34
T1-weighted imaging is performed as in-phase and out-of-phase chemical shift gradient-recalled echo sequences prior to contrast administration. This is useful in evaluation of focal fat containing lesions and diffuse pathology like hepatic steatosis and iron overload.35 In-phase (IP) and out-of-phase (OP) imaging is performed with a TE of 2.1 msec and 4.2 msec, respectively on 3T magnets. Both the images can be obtained in one TR by use of a double echo technique.35
T2-weighted images are acquired in the axial and coronal planes using a breath-hold or non-breath-hold technique. These include the accelerated fast spin-echo or single-shot accelerated fast spin-echo (half-Fourier single-shot turbo spin-echo (HASTE) or single shot fast spin-echo (SSFSE)) sequences. Respiratory compensation or respiratory triggering is employed whenever non-breath-hold sequences are used. An echo train length (ETL) of 16–20 provides optimal T2-weighted images in short scan time.35 Echo-train spin echo sequences acquired as contiguous thin 2D sections or as a thick 3D volume slab, also form the basis for MR cholangiography.
The TE of T2-weighted images is usually around 80-90 msec and longer TE (150–250 msec) T2W imaging can be used to differentiate between cysts and solid lesions.
The liver parenchyma appears homogeneous on both T1 and T2-weighted images. The liver shows moderate signal intensity on T1W images, similar to the pancreas but brighter than spleen and kidneys (Figs 1.19A and B). On T2W images (Fig. 1.20), the liver appears dark and has signal intensity less than that of spleen.
Post-contrast administration, dynamic fat-suppressed MR imaging (Figs 1.21A to D) is performed using a 2-D or 3-D technique. Contrast is administered at a dose of 0.1 mmol/kg at a rate of 2 mL/s and followed by saline flush.36 Pre-contrast scan is followed by the acquisition of scans in the late arterial (20 seconds after administration of contrast), portal venous (60–80 seconds) and delayed (2–5 minutes) phases. The bolus timing technique (includes automated bolus detection system or fluoroscopic triggering) or acquisition of multiple repeated arterial-phase datasets is used for planning the arterial phase. Additional delayed images (more than 5 minutes) may be required in cases of hemangiomas, vascular malformations, or cholangiocarcinomas.37,38 Subtracted images (subtraction of the pre-contrast scan from the post-contrast scan) should be generated in cases of T1 hyperintense lesions.
The use of hepatobiliary specific MR contrast agents is recommended for liver imaging. When gadobenate dimeglumine (Multihance) is used, one hour delayed scan is performed. However, with the use of gadoxetate (Eovist), hepatobiliary phase is obtained at 20 minutes post-contrast injection. This phase is used to document retention of contrast in lesions like focal nodular hyperplasia and to better delineate the biliary anatomy. However, it is important to obtain MRCP images (T2-weighted imaging of biliary tree) before biliary excretion of contrast, as the enhanced bile is not visualized on the MRCP images. For optimal time utilization, T2-weighted and diffusion-weighted images can be obtained after the injection of gadoxetate disodium.34
Diffusion-weighted images are obtained using echo-planar imaging (EPI) with breath held, free breathing, or respiratory-gated techniques. Imaging time can be reduced with the use of parallel imaging. DWI is performed with at least two b-values (b=20–50 s/mm2 and b=400 to 1000 s/mm2).
zoom view
Figs 1.19A and B: T1-weighted imaging for the liver. In-phase (A) and out-of-phase (B) chemical shift gradient-recalled echo sequences are performed prior to contrast administration. Liver shows homogeneous moderate signal intensity, greater than that of the spleen
15
zoom view
Fig. 1.20: Axial T2 WI fat suppressed sequence reveals homogeneous signal intensity of the liver. Note the signal intensity of liver is less than that of spleen
The use of ADC maps and calculation of ADC values is recommended to identify T2 shine through effect, which can be a confounding factor in the interpretation of DW images. DWI is useful in characterization of focal liver lesions, liver fibrosis and screening of the entire abdomen for additional lesions. It is of particular use in patients with contraindications to MR contrast medium. However, it is important to view the DWI images in conjunction with the other sequences and amalgamate, its findings with the morphology and enhancement characteristics for increased accuracy of diagnosis.34
 
MRI of Pancreatic Pathology
For the evaluation of pancreatic pathology, T1-weighted images are acquired as dual-echo GRE images in the axial plane and T2-weighted images as turbo spin-echo sequences in the axial and coronal plane. MRCP sequences using both 2D and 3D fast SE techniques are used to delineate the pancreaticobiliary anatomy.
zoom view
Figs 1.21A to D: Multiphase MRI liver. Post-contrast (Gadobenate dimeglumine/Multihance) administration, T1-weighted fat suppressed gradient echo images are obtained at 20 seconds [late arterial phase] (A), 65 seconds [portal venous phase] (B), 180 seconds [delayed phase] (C) and 1 hour [hepatobiliary phase] (D) in a patient of chronic liver disease. No focal lesion was detected
16Intravenous gadolinium based contrast medium is injected at a dose of 0.1 mmol/kg of body weight and dynamic scanning is performed. This includes the acquisition of arterial (20 sec after injection of contrast medium), portal venous (45–65 seconds) and equilibrium phase (3–5 min) images. Some authors recommend a coronal plane (parallel to the bifurcation of the portal vein) T1 GRE acquisition two minutes after the injection of contrast medium.26,39
 
MAGNETIC RESONANCE ENTEROGRAPHY
This is a noninvasive technique for the evaluation of small bowel pathology. Since there is no radiation exposure, it is the modality of choice for pediatric patients and monitoring of patients of inflammatory bowel disease.
Patient preparation includes fasting for 6 hours and intestinal cleansing as for CT enterography.
Biphasic contrast agents (hyperintense on T2-weighted and hypointense on T1-weighted sequences) are preferred as they provide maximal contrast with bowel wall on the post-contrast sequences. These include agents like water, mannitol, locust bean gum, low-dose barium, manganese compounds, and polyethylene glycol. The protocol varies with institutions and a suggested protocol is given in Table 1.7. Some centers advocate prone position as it decreases respiratory excursion and enables better separation of bowel loops.16,40
Images are acquired in both the axial and coronal planes (Figs 1.22A and B). T2W imaging can be performed as spin-echo sequence (TSE or FSE), gradient-echo (GRE) sequence, or a hybrid gradient and spin-echo (GRASE) sequence.
Table 1.7   MR enterography protocol
  • Fasting for 6 hours
  • Oral contrast
    • 300 mL of 20% mannitol mixed with 1.5 L of water
    • Administered in divided aliquots over 1 hour
  • Intravenous contrast
    • 0.1 mmol/kg of gadolinium-based agent
    • Single phase acquisition at 50 sec (enteric phase)
  • IV buscopan (1 mL~20 mg): after acquisition of cine BTFE
  • Sequences:
    • Steady state fast field echo (Cine): Coronal
    • Steady state fast field echo: Axial
    • T2W FS: Axial, coronal
    • T1W Non FS: Axial
    • DWI (b VALUE 0, 400, 800): Axial
    • Post-contrast T1W FS: Axial, coronal
zoom view
Figs 1.22A and B: MR enterography. Coronal T2-weighted fat suppressed fast spin echo (A) and post-gadolinium coronal T1 fat suppressed gradient echo (B) acquisition shows good bowel distension and no abnormal enhancement
17Single shot technique is more useful as it is relatively insensitive to motion. Fat suppressed sequences are preferred for the evaluation of active inflammation. T1 imaging can be performed as spin echo or gradient echo sequences with T1W 3-D gradient-echo sequence having the advantage of short scan time allowing image acquisition within a single breath-hold.
“Cine imaging” of the bowel is real time, dynamic imaging of a predefined region of interest by employing a heavily T2W coronal slab or a single-shot steady-state free precession sequence. This is useful for the identification of fibrotic strictures.40
 
NUCLEAR IMAGING
Neuroendocrine tumors (NET) like carcinoids and pancreatic NET express somatostatin receptors (SSTR) at the cell membrane.41 Functional imaging uses the affinity of somatostatin receptor analogs for tissues, which express SSTR. There are six main subtypes of SSTR (1–5 including 2A and 2B) with SSTR-2 and SSTR-5 being the most commonly expressed in NET.
Octreotide scintigraphy (using octreotide labeled with indium 111) is the standard functional imaging modality for NET's. It is combined with single photon emission computed tomography for improved spatial resolution. It is also used to evaluate the response to treatment and for metastatic work-up of NET.42 This technique has greater sensitivity for carcinoids and gastrinomas than insulinomas.42
Iodine 123 (123I) MIBG scintigraphy: This technique uses Metaiodobenzyl guanidine, which is a norepinephrine analog and binds to the norepinephrine transporter in NET.
PET/CT: Newer analogs labeled with gallium-68 are now used in combination with PET-CT imaging. However, they have more affinity to the SSTR-2 receptors than to the SSTR-3 and SSTR-5 receptors. Compared with octreotide scintigraphy, PET/CT requires less time and has a higher spatial resolution. In addition, the production of 68Ga-DOTA peptides is relatively less costly as it does not require a cyclotron.
Three types of 68Ga-DOTA-peptide analogs are available:
  • 68Ga-DOTA-Phe1-Tyr3Octreotide (TOC)
  • 68Ga-DOTA-NaI3-Octreotide (NOC)
  • 68Ga-DOTA-Tyr3Octreotate (TATE)
Out of these, DOTA-NOC has good affinity for SSTR-3 in addition to SSTR-2 and SSTR-5 receptors and is preferred as a broad-spectrum agent.43
68Ga-DOTANOC PET enterography is useful for delineation of small bowel carcinoids.16
18F FDG is also used as a glucose analog in FDG PET (can be combined with CTE/CTC for evaluation of bowel neoplasms and inflammatory bowel disease) and 18F DOPA is used as a catecholamine analog for DOPA PET in the evaluation of NET.16,44
 
ANGIOGRAPHY
Conventional hepatic/mesenteric angiography is now seldom used for diagnostic purpose as CT and MR imaging can generate high quality angiographic images in a non-invasive manner. The use of catheter angiography is now restricted to vascular interventions.
 
Technique
Coagulation profile and serum creatinine should be available prior to the procedure. The femoral artery is the preferred approach and Seldinger technique is used for the puncture. Angiography of the liver is performed by selective injections of the celiac axis and superior mesenteric artery (SMA) or one or more of their branches. A 5-French right angle or reverse curve catheter such as Cobra is commonly used. The volume of contrast used is about 20–30 cc injected at a rate of 5–6 cc per second. The portal venous system is visualized by injecting the splenic artery or SMA coupled with prolonged filming.
 
Anatomy
The celiac axis (Fig. 1.23) is the first major branch of the abdominal aorta and it gives rise to three major branches (the common hepatic, left gastric, and splenic arteries). The common hepatic artery gives rise to the gastroduodenal artery after which it becomes the proper hepatic artery. The proper hepatic artery divides into the right and left hepatic arteries, which further divide to supply the corresponding segments. The main branches of the gastroduodenal artery are the retroduodenal, superior pancreaticoduodenal and right gastroepiploic arteries. The splenic artery gives rise to short gastric branches and the left gastroepiploic artery. The superior mesenteric artery (SMA) arises approximately 1 cm caudad to the celiac trunk and supplies the small bowel through the inferior pancreaticoduodenal, jejunal, and ileal arteries. The right colon is supplied by the ileocolic, right colic and middle colic artery branches of the superior mesenteric artery forming an arcade (marginal artery of Drummond), which anastomoses with the branches of the inferior mesenteric artery (IMA). The branches of the IMA include left colic artery, sigmoidal artery, rectosigmoid artery and superior rectal artery.45
 
CONCLUSION
The imaging techniques for abdomen have evolved considerably in the past few years. Conventional radiographs and barium studies now have limited role in the evaluation of GI pathology. Recent advances in ultrasound like endosonography, elastography and contrast studies have significantly improved the diagnostic yield of a noninvasive and radiation free modality like ultrasound.18
zoom view
Fig. 1.23: Intra-arterial DSA showing selective celiac axis injection, splenic artery (SA), left gastric artery (LGA), common hepatic artery (CHA), gastroduodenal artery (GDA), right hepatic artery (RHA) and left hepatic artery (LHA)
Cross-sectional modalities like CT and MRI remain the mainstay in the diagnosis and follow-up of most abdominal pathologies. A judicious use of the currently available imaging modalities is required for appropriate diagnosis and treatment of various abdominal diseases.
REFERENCES
  1. Maglinte DDT, Sandrasegaran K, Chiorean M, Dewitt J, McHenry L, Lappas JC. Radiologic investigations complement and add diagnostic information to capsule endoscopy of small-bowel diseases. AJR. 2007;189:306–12.
  1. Maglinte DDT. Capsule imaging and the role of radiology in the investigation of diseases of the small bowel. Radiology 2005;236:763–7.
  1. Halligan S, Robinson PJA. The large bowel: In: David Sutton (Ed). Textbook of Radiology and Imaging, 7th edn. Churchill Livingstone. 
  1. American College of Radiology. ACR practice parameter for the performance of esophagrams and upper gastrointestinal examinations in adults. http://www.acr.org/~/media/5223A3FBC92E40378DF6E55FB8E6134B.pdf. Accessed on September 07, 2016.
  1. American College of Radiology. ACR practice parameter for the performance of a barium small bowel examination in adults. http://www.acr.org/~/media/9408bdfc3c234e4287bd8610faafe3f1.pdf. Accessed on September 07, 2016.
  1. American College of Radiology. ACR–SAR practice parameter for the performance of an enteroclysis examination in adults. http://www.acr.org/~/media/0CEECEA90E154EB99FC6562F1311E7E4.pdf. Accessed on September 07, 2016.
  1. American College of Radiology. ACR practice parameter for the performance of fluoroscopic contrast enema examination in adults. http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Fluoroscopic_Contrast_Enema.pdf. Accessed on September 07, 2016.
  1. Kono Y, Mattrey RF. Ultrasound of the liver. The Radiologic Clinics of North America. 2005;43(5):815–26.
  1. Gazelle GS, Saini S, Mueller PR, (Eds). Hepatobiliary and Pancreatic Radiology: Imaging and Intervention. New York, NY, USA: Thieme Medical Publishers,  1998.
  1. Kusera JN, Kucera S, Perrin SD, Caracciolo JT, Schmulewitz N, Kedar RP. Cystic lesions of the pancreas: Radiologic endosonographic correlation. Radiographics. 2012;32:E283–E301.
  1. Frulio N, Trillaud H. Ultrasound elastography in liver. Diagn Interv Imaging. 2013;94:515–34.
  1. Ferraioli G, Parekh P, Levitov AB, Filice C. Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med. 2014;33:197–203.
  1. Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: Preparation and application. AJR. 2012;199:292–9.
  1. Catalano O, Nunziata A, Lobianco R, Siani A. Real-time harmonic contrast material-specific us of focal liver lesions. Radiographics. 2005;25:333–49.
  1. American College of Radiology. ACR–SPR practice parameter for the performance of computed tomography (CT) of the abdomen and computed tomography (CT) of the pelvis. http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/CT_Abdomen_Pelvis.pdf. Accessed on September 07, 2016.
  1. Das CJ, Manchanda S, Panda A, Gupta AK, Sharma A. Recent advances in imaging of small and large bowel. PET Clin. 2016;11:21–37.
  1. Iannaccone R, Laghi A, Catalano C, et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005;234(2):460–7.
  1. Doyle DJ, O'Malley ME, Jang HJ, Jhaveri K. Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr. 2007;31(1):86–92.
  1. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: Part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014;272:635–54.
  1. McEvoy SH, McCarthy CJ, Lavelle LP, Moran DE, Cantwell CP, Skehan SJ. Hepatocellular carcinoma: Illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American association for the study of liver diseases. Radiographics. 2013;33:1653–68.
  1. Oto A, Tam EP, Szklaruk J. Multidetector row CT of the liver. The Radiologic Clinics of North America. 2005;43(5):827–48.
  1. Kim MJ, Choi JY, Lim JS, et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. Am J Roentgenol. 2006;187(1):198–206.

  1. 19 Laghi A, Iannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F. Hepatocellular carcinoma: Detection with triple-phase multi–detector row helical CT in patients with chronic hepatitis. Radiology. 2003;226:543–9.
  1. Coursey CA, Nelson RC, Boll DT, Paulson EK, Ho LM, Neville AM. Dual-energy multidetector CT: How does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics. 2010;30:1037–55.
  1. Wigmore SJ, Redhead DN, Yan XJ, et al. Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg. 2001;233: 221–6.
  1. Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: A state-of-the-art review. World J Gastroenterol. 2014;20:7864–77.
  1. Chaudhary V, Bano S. Imaging of the pancreas: Recent advances. Indian J Endocrinol Metab. 2011;15:S25–32.
  1. Manchanda SD, Prasad A, Sachdev N, De P, Abbas SZ, Baruah BP. Multidetector computed tomography (MDCT) evaluation of small bowel obstruction: pictorial review. Trop Gastroenterol. 2010;31:249–59.
  1. American College of Radiology. ACR–SAR–SPR practice parameter for the performance of computed tomography (CT) enterography. http://www.acr.org/~/media/99D260410DF44A3BA01F1AB716DE8F2F.pdf. Accessed on September 07, 2016.
  1. American College of Radiology. ACR–SAR–SCBT-MR practice parameter for the performance of computed tomography (CT) colonography in adults. http://www.acr.org/~/media/A81531ACA92F45058A83B5281E8FE826.pdf. Accessed on September 07, 2016.
  1. American College of Radiology. ACR–SAR–SPR practice parameter for the performance of magnetic resonance imaging (MRI) of the abdomen (excluding the liver). http://www.acr.org/~/media/8f5bc61adb114c5b9e46fe6914461d25.pdf. Accessed on September 07, 2016.
  1. Soher BJ, Dale BM, Merkle EM. A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am. 2007; 15(3):277–90.
  1. Leyendecker JR, Childs DD. Kidneys and MR urography. Magn Reson Imaging Clin N Am. 2007;15(3):373–82.
  1. American College of Radiology. ACR–SAR–SPR practice parameter for the performance of magnetic resonance imaging (MRI) of the liver. http://www.acr.org/~/media/6B520D299C0B4B018A90BE21A79D4F72.pdf. Accessed on September 07, 2016.
  1. Maniam S, Szklaruk J. Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging. World J Radiol. 2010;2:309–22.
  1. Arif-Tiwari H, Kalb B, Chundru S, Sharma P, Costello J, Guessner RW, Martin DR. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol. 2014;20:209–21.
  1. Runge VM. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comput Assist Tomogr. 1998;22(4):643–50.
  1. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma: 2. Hilar cholangiocarcinoma. Am J Roentgenol. 1995;165(6):1433–6.
  1. Sandrasegaran K, Lin C, Akisik FM, Tann M. State-of-the-art pancreatic MRI. AJR. 2010;195:42–53.
  1. American College of Radiology. ACR–SAR–SPR practice parameter for the performance of magnetic resonance (MR) enterography. http://www.acr.org/~/media/99F8D0F593E64860AA3B1EC6CA1C758D.pdf. Accessed on September 07, 2016.
  1. Woodbridge LR, Murtagh BM, Yu DFQC, Planche KL. Midgut neuroendocrine tumors: Imaging assessment for surgical resection. Radiographics. 2014;34:413–26.
  1. Virgolini I, Traub-Weidinger T, Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19:213–27.
  1. Sharma P, Singh H, Bal C, Kumar R. PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India. Indian J Nucl Med. 2014;29:2–12.
  1. Sahani DV, Bonaffini PA, Castillo CFD, Blake MA. Gastroenteropancreatic neuroendocrine tumors: Role of imaging in diagnosis and management. Radiology. 2013;266:38–61.
  1. Stallard DJ, Tu RK, Gould MJ, Pozniak MA, Pettersen JC. Minor vascular anatomy of the abdomen and pelvis: A CT atlas. RadloGraphlcs. 1994;14:493–513.